<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="review-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">50848</article-id><article-id pub-id-type="doi">10.7554/eLife.50848</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Multifaceted roles of microRNAs: From motor neuron generation in embryos to degeneration in spinal muscular atrophy</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-152303"><name><surname>Chen</surname><given-names>Tai-Heng</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7713-3627</contrib-id><email>taihen@kmu.edu.tw</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-35833"><name><surname>Chen</surname><given-names>Jun-An</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9870-3203</contrib-id><email>jachen@imb.sinica.edu.tw</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">PhD Program in Translational Medicine, Graduate Institute of Clinical Medicine</institution><institution>Kaohsiung Medical University, Academia Sinica</institution><addr-line><named-content content-type="city">Kaohsiung</named-content></addr-line><country>Taiwan</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Pediatrics, Division of Pediatric Emergency</institution><institution>Kaohsiung Medical University Hospital, Kaohsiung Medical University</institution><addr-line><named-content content-type="city">Kaohsiung</named-content></addr-line><country>Taiwan</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Institute of Molecular Biology</institution><institution>Academia Sinica</institution><addr-line><named-content content-type="city">Taipei</named-content></addr-line><country>Taiwan</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Faculty of Medicine, College of Medicine</institution><institution>Kaohsiung Medical University</institution><addr-line><named-content content-type="city">Kaohsiung</named-content></addr-line><country>Taiwan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Reviewing Editor</role><aff><institution>California Institute of Technology</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>18</day><month>11</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>8</volume><elocation-id>e50848</elocation-id><history><date date-type="received" iso-8601-date="2019-08-06"><day>06</day><month>08</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-11-05"><day>05</day><month>11</month><year>2019</year></date></history><permissions><copyright-statement>Â© 2019, Chen and Chen</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Chen and Chen</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-50848-v1.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.50848.001</object-id><p>Two crucial questions in neuroscience are how neurons establish individual identity in the developing nervous system and why only specific neuron subtypes are vulnerable to neurodegenerative diseases. In the central nervous system, spinal motor neurons serve as one of the best-characterized cell types for addressing these two questions. In this review, we dissect these questions by evaluating the emerging role of regulatory microRNAs in motor neuron generation in developing embryos and their potential contributions to neurodegenerative diseases such as spinal muscular atrophy (SMA). Given recent promising results from novel microRNA-based medicines, we discuss the potential applications of microRNAs for clinical assessments of SMA disease progression and treatment.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Developmental Biology</kwd><kwd>Human Biology and Medicine</kwd><kwd>Neuroscience</kwd><kwd>Stem Cell and Regenerative Medicine</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004663</institution-id><institution>Ministry of Science and Technology, Taiwan</institution></institution-wrap></funding-source><award-id>108-2311-B-001-011</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Jun-An</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004663</institution-id><institution>Ministry of Science and Technology, Taiwan</institution></institution-wrap></funding-source><award-id>106-2314-B-037-086</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Tai-Heng</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004737</institution-id><institution>National Health Research Institutes</institution></institution-wrap></funding-source><award-id>NHRI-EX108-10831NI</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Jun-An</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001869</institution-id><institution>Academia Sinica</institution></institution-wrap></funding-source><award-id>CDA-107-L05</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Jun-An</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004694</institution-id><institution>Kaohsiung Medical University</institution></institution-wrap></funding-source><award-id>KMUH104-4M52</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Tai-Heng</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004694</institution-id><institution>Kaohsiung Medical University</institution></institution-wrap></funding-source><award-id>KMUH105-5M49</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Tai-Heng</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Summary review of microRNA roles during motor neuron generation and degeneration.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>How neurons establish individual identity in the developing nervous system and why only specific neuron subtypes are susceptible to degeneration in neurodegenerative disease are two challenging unanswered questions in neuroscience. Answers to these questions are crucial to establishing the patterns of connectivity between neuronal types and their selective targets. Deciphering neuronal subtype is relatively straightforward in <italic>Caenorhabditis elegans</italic>, as each neuronal lineage and its position, pattern of connectivity, molecular profile, and function have all been well characterized (<xref ref-type="bibr" rid="bib52">Hobert, 2008</xref>). However, the complex array of neurons in the vertebrate nervous system (e.g., 10<sup>11</sup> in the human brain) renders it rather more challenging to define a neuronal type. Thus, a clear neuronal taxonomy that completely reconciles morphological, physiological, molecular, and perhaps other criteria (e.g., position, connectivity) is essential. Neuronal diversity in the central nervous system (CNS) was vividly described by Sir Roger Penrose: â<italic>If you look at the entire physical cosmos, our brains are a tiny, tiny part of it. But they're the most perfectly organized part. Compared to the complexity of a brain, a galaxy is just an inert lump</italic>â.</p><p>The mechanisms leading to neuronal diversity in the CNS is arguably best characterized by spinal motor neurons (MNs). Within the vertebrate spinal cord, the cell bodies of MNs innervating specific muscle targets are topographically organized within columnar, divisional, and pool subtypes (<xref ref-type="bibr" rid="bib74">Lance-Jones and Landmesser, 1981</xref>; <xref ref-type="bibr" rid="bib75">Landmesser, 1978a</xref>; <xref ref-type="bibr" rid="bib76">Landmesser, 1978b</xref>). Spinal MNs are diversified into hundreds of subtypes along the rostrocaudal (RC) axis (<xref ref-type="fig" rid="fig1">Figure 1</xref>) (<xref ref-type="bibr" rid="bib14">Catela et al., 2015</xref>). Spinal MNs are located in the ventral horn of the spinal cord and transmit signals from the brain to innervated muscle targets in the periphery to control all muscle movements. The human body contains more than 300 bilateral pairs of muscles andÂ ~100 million muscle fibers. The control of muscular contractions for different motor behaviors relies on MN diversity (<xref ref-type="bibr" rid="bib14">Catela et al., 2015</xref>; <xref ref-type="bibr" rid="bib64">Kanning et al., 2010</xref>). Stereotypic axonal projection by MNs suggests the existence of MN subtype identities, which would facilitate selectivity in innervation patterns of different muscle targets. MNs can find their original targets even if they have been displaced to another segment of the spinal cord before axonal extension, which indicates that most MNs are programmed with an intrinsic identity that encodes information on their targeting preference (<xref ref-type="bibr" rid="bib73">Lance-Jones and Landmesser, 1980</xref>). Moreover, MN subtypes exhibit differential vulnerability in MN-related degenerative diseases that cause progressive muscle weakness and paralysis, such as adult-onset amyotrophic lateral sclerosis (ALS) and childhood spinal muscular atrophy (SMA), further support an intrinsic susceptibility to degeneration amongst MN subtypes. Thus, a comprehensive understanding of the underlying mechanisms for MN diversification will likely shed light on MN target selectivity, subtype survival and differential vulnerability to MN-related diseases.</p><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.50848.002</object-id><label>Figure 1.</label><caption><title>Topographic distribution of motor neuron (MN) columnar identities along the rostrocaudal axis of the spinal cord.</title><p>(<bold>A</bold>) Schematic illustration of the three-dimensional arrangement of motor columns in the spinal cord. Limb-innervating MNs are located in the lateral motor columns (LMC) at brachial and lumbar levels, whereas preganglionic (PGC) and hypaxial (HMC) neurons at thoracic levels innervate the sympathetic ganglia and hypaxial muscles, respectively. Medial motor (MMC) neurons are distributed at all rostrocaudal levels and project dorsally to epaxial muscles. (<bold>B</bold>) Diagram illustrating transverse sections through each segment, depicting the directions of MN axonal projection to the muscle targets.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50848-fig1-v1.tif"/></fig><p>Spinal MNs are delineated according to the combinatorial actions of three homeodomain-containing transcription factors (TFs) â Nkx2.2, Nkx6.1 and Irx3 â that confine the generation of motor neuron progenitors (pMNs) to the appropriate region of the neural tube (<xref ref-type="bibr" rid="bib6">Balaskas et al., 2012</xref>; <xref ref-type="bibr" rid="bib11">Briscoe et al., 2000</xref>) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Nkx2.2 and Irx3 initially ensure that pMNs are induced in the ventral spinal cord. Once pMNs have been defined, Nkx6.1 activity promotes the pMN-restricted induction of downstream factors, such as the basic helix-loop-helix (bHLH) factor Olig2 (<xref ref-type="bibr" rid="bib100">Novitch et al., 2001</xref>). Olig2 has a dual role in coordinating the acquisition of pan-neuronal properties and subtype characteristics of differentiating MNs. Forced expression of Olig2 in the dorsal region is sufficient to repress Irx3. Recent studies have further revealed the gene-regulatory network (GRN) of these progenitor TFs responsible for establishing cell identities in the developing spinal cord, with progenitor domains being determined by a network of transcriptional repressors that repress all inappropriate and alternative cell fates to elicit a single definitive identity (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) (<xref ref-type="bibr" rid="bib69">Kutejova et al., 2016</xref>). Additionally, progenitor domain-specific master TFs also directly repress âeffectorâ genes expressed in other progenitor domains. For example, pMN-master regulator Olig2 directly represses alternative interneuron domain TFs such as Pax6, Irx3, and Nkx2.2. In <italic>Olig2</italic> mutants, Pax6 and Nkx2.2 are ectopically expanded into pMNs, supporting the concept of cross-repressive TF-mediated GRN in the pMNs (<xref ref-type="bibr" rid="bib6">Balaskas et al., 2012</xref>; <xref ref-type="bibr" rid="bib146">Zhou and Anderson, 2002</xref>).</p><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.50848.003</object-id><label>Figure 2.</label><caption><title>Transcription factor-based dorsoventral (DV) and rostrocaudal (RC) pattering of the spinal cord.</title><p>(<bold>A</bold>) Upon neural tube closure, a gradient of Sonic hedgehog protein (Shh) emanating from the notochord (NC) and floor plate (FP), together with BMP/TGFÎ² signaling from the roof plate (RP), mediates repression of class I homeodomain proteins (e.g. Irx3 and Pax6) and induction of class II protein expression (e.g. Nkx6.1 and Nkx2.2) at different threshold concentrations. Retinoic acid (RA) is expressed by the paraxial mesoderm to induce expression of class I proteins, which are turned off more ventrally by threshold levels of Shh. Class I and class II proteins that abut each other to define progenitor domain boundary respectively. Shh signaling defines five progenitors (p0-p3 and pMN) that give rise to V0-V3 interneurons and motor neurons. S, somite; RP, roof plate; BMP, bone morphogenetic proteins; TFGÎ²s, transforming growth factor beta. (<bold>B</bold>) Isl1âLhx3 forms MN-hexamer complexes to direct the differentiation of MNs by binding to MN enhancers. Isl1âLhx3 induces the expression of a battery of MN genes that give rise to functional hallmarks of MNs, while suppressing key interneuron genes. Furthermore, the Isl1-Lhx3 complex amplifies its own expression through a potent autoregulatory feedback loop and simultaneously enhances the transcription of Lmo4 to promote MN differentiation and maturation. (<bold>C</bold>) Fibroblast growth factor (FGF) signals maintain a caudal progenitor zone during axis extension, and down-regulation of FGF signaling by RA is required for neuronal patterning and differentiation at more rostral levels. The RA and FGF gradient elicits expression of Hox genes along the rostrocaudal axis. Similar to patterning along the dorsoventral axis, the coordinated interactions between Hox family members allow regional boundaries to be delineated. Specific expression of Hox accessory factors, such as Foxp1, can further specify MN columnar subtypes. Within lateral motor columns, MN pools that innervate different limb muscle types can be defined by hallmark transcription factors (TFs) such as Runx1, Pea3, Scip, Nkx6.1, as well as digit-innervating MNs that manifest Fign, Cpne4, or other TFs.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50848-fig2-v1.tif"/></fig><p>After pMNs have been defined within the neural tube, both cell proliferation and cell cycle exit are patterned in time and space to regulate MN subtypes (<xref ref-type="bibr" rid="bib66">Kicheva et al., 2014</xref>). In anamniotes, maintenance of pMNs also requires an MN-specific Cyclin Dx (Ccndx). Inhibition of Ccndx results in specific loss of differentiated MNs (<xref ref-type="bibr" rid="bib16">Chen et al., 2007</xref>; <xref ref-type="bibr" rid="bib80">Lien et al., 2016</xref>). Given that overexpression of D-type cyclin in amniotes appears insufficient to alter the cell-fate decision and timing of neuronal differentiation in the spinal cord, it is not clear if higher vertebrates need specific cyclins to replenish pMNs to generate the diverse subtypes of MNs and oligodendrocytes (<xref ref-type="bibr" rid="bib83">Lobjois et al., 2008</xref>). In mouse embryos, spinal MNs acquire generic MN identity after cell cycle exit (i.e., at about embryonic day 9.5), and express a common set of TFs â Mnx1 (Hb9), Lhx3, Isl1 and Isl2 (<xref ref-type="bibr" rid="bib100">Novitch et al., 2001</xref>; <xref ref-type="bibr" rid="bib121">Thaler et al., 1999</xref>; <xref ref-type="bibr" rid="bib125">Tsuchida et al., 1994</xref>) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). These MNs project axons outside the spinal cord to peripherals and release acetylcholine as a neurotransmitter. Generic spinal MN identity is established by cooperative binding of the LIM complex comprising Isl1 and Lhx3 to MN-specific enhancers, thereby inducing the expression of a battery of MN genes that induce functional hallmarks of MNs, while suppressing key interneuron genes. Furthermore, the Isl1-Lhx3 complex amplifies its own expression through a potent autoregulatory feedback loop and simultaneously enhances the transcription of <italic>Lmo4</italic> to promote MN differentiation and maturation (<xref ref-type="bibr" rid="bib35">Erb et al., 2017</xref>; <xref ref-type="bibr" rid="bib77">Lee et al., 2012</xref>) (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p><p>As embryonic development progresses, MNs diversify to exhibit subtype identities. Establishment of MN subtype is mediated by mutually exclusive expression of Hox TFs, which is programmed according to body segment along the RC axis. For example, segmental identity of MNs is defined by the mutually exclusive expression of Hox6, Hox9 and Hox10 (<xref ref-type="bibr" rid="bib20">Dasen et al., 2003</xref>; <xref ref-type="bibr" rid="bib72">Lacombe et al., 2013</xref>) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). In particular, a single <italic>Hox</italic> gene, <italic>Hoxc9</italic>, required for the generation of thoracic MN subtypes, is essential for organizing the MN topographic map, and acts as a key repressor of the forelimb-level <italic>Hox</italic> network (<xref ref-type="bibr" rid="bib61">Jung et al., 2010</xref>). In each segment, MNs are grouped into different columns according to their innervating targets. For instance, within the brachial segment hosting Hox6 expression, MNs are further grouped into axial muscle-projecting MNs (Lhx3<sup>on</sup>, MMC) and forelimb-innervating MNs (Foxp1<sup>on</sup>, LMC)(<xref ref-type="bibr" rid="bib22">Dasen et al., 2008</xref>). Within Hoxc6<sup>on</sup> MNs, expression of another set of mutually exclusive Hox proteins, such as Hox5 and Hox8 in Foxp1<sup>on</sup> LMC, controls the rostral and caudal motor pool identity, which directs motor pools to either innervate proximal or distal muscles in the forelimb (<xref ref-type="bibr" rid="bib14">Catela et al., 2015</xref>). Although a mutually exclusive expressed Hoxa5-Hoxc8 sharp boundary is manifested within the Hoxc6<sup>on</sup> MNs, unlike progenitor-TFs that display mutual inhibitions, only Hoxc8 represses Hoxa5 unilaterally at protein level (<xref ref-type="bibr" rid="bib21">Dasen et al., 2005</xref>; <xref ref-type="bibr" rid="bib79">Li et al., 2017</xref>). It is therefore expected that additional Hox-mediated GRNs might be needed to consolidate the robust boundary within the brachial LMC-MNs.</p><p>LMC is the most extensively studied motor column, and this motor column is further classified into divisional identities targeting flexor and extensor limb muscles (<xref ref-type="bibr" rid="bib63">Kania and Jessell, 2003</xref>; <xref ref-type="bibr" rid="bib113">Sockanathan and Jessell, 1998</xref>). Further heterogeneity in spinal MNs can be revealed by retrograde labeling of each muscle group, with labeled MNs occupying distinct and stereotyped positions in the spinal cord (<xref ref-type="bibr" rid="bib53">Hollyday, 1980a</xref>; <xref ref-type="bibr" rid="bib54">Hollyday, 1980b</xref>; <xref ref-type="bibr" rid="bib75">Landmesser, 1978a</xref>; <xref ref-type="bibr" rid="bib76">Landmesser, 1978b</xref>; <xref ref-type="bibr" rid="bib89">McHanwell and Biscoe, 1981</xref>; <xref ref-type="bibr" rid="bib109">Romanes, 1964</xref>; <xref ref-type="bibr" rid="bib118">SÃ¼rmeli et al., 2011</xref>; <xref ref-type="bibr" rid="bib130">Vanderhorst and Holstege, 1997</xref>). Therefore, MN subtypes can be further assigned into pool identity according to innervated muscle targets. It is believed that one of the physiological functions of MN pool diversification during development is to enable precise target selection. However, it remains unclear how each MN subtype establishes its selectivity to target distinct muscle fibers. Many studies have revealed that a number of proteins â including LIM-HD, bHLH, Hox and ETS-TFs â play major roles in establishing MN subtype identity and connectivity during development (<xref ref-type="bibr" rid="bib21">Dasen et al., 2005</xref>; <xref ref-type="bibr" rid="bib63">Kania and Jessell, 2003</xref>; <xref ref-type="bibr" rid="bib125">Tsuchida et al., 1994</xref>; <xref ref-type="bibr" rid="bib132">Vermot et al., 2005</xref>)Â (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). For example, Nkx6.1 and Nkx6.2 are expressed in subpopulations of MNs and loss-of-function studies of these proteins have resulted in target innervation and arborization defects in adductor and gracilis muscles (<xref ref-type="bibr" rid="bib23">De Marco Garcia and Jessell, 2008</xref>; <xref ref-type="bibr" rid="bib43">Ghosh and Kolodkin, 1998</xref>; <xref ref-type="bibr" rid="bib82">Livet et al., 2002</xref>). In addition, extrinsic cues are also indispensable for precisely defining MN subtype diversification and axon targeting. For example, expression of the ETS-TF <italic>Etv4</italic> (Pea3) in MNs innervating cutaneous maximus and latissimus dorsi muscles in the forelimb requires GDNF signal activation from the periphery (<xref ref-type="bibr" rid="bib46">Haase et al., 2002</xref>). Recently, Jessell and colleagues revealed that <italic>Cpne4</italic>/<italic>Fign</italic> markers and evasion of non-canonical retinoic acid signaling label the MN subtype innervating digit muscles, providing insights into the emergence of a divergent molecular program during evolution (<xref ref-type="bibr" rid="bib92">Mendelsohn et al., 2017</xref>). Even though 60 motor pools are thought to exist in either the brachial or lumbar LMC-MNs innervating mouse limb muscles, a complete subtype-specific gene profile for each motor pool is still lacking, not to mention for the other less well-profiled motor columns (<xref ref-type="bibr" rid="bib31">DâElia and Dasen, 2018</xref>; <xref ref-type="bibr" rid="bib38">Fetcho, 1987</xref>) (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p><p>Above all, spinal MN diversity is initiated by differential distribution of extrinsic morphogen signals, which elicit a set of cardinal TFs to abut each other and consolidate the cell fate of pMNs along the dorsoventral (DV) axis. Consequently, MN subtypes are distributed topographically along the RC axis in the spinal cord to align innervating muscle targets during development. Although the morphogen-mediated GRN can explain most of the principles leading to MN diversity, it is still not adequate to establish how cells at the boundaries exposed to similar morphogen thresholds adopt an âall or noneâ choice. Furthermore, TF-mediated cell fate determination is insufficient for generating a finer resolution of MN subtypes within a particular segment, so other regulatory pathways must be employed.</p></sec><sec id="s2"><title>MicroRNAs during motor neuron development</title><p>The patterning of the developing CNS relies on precise control of spatial and temporal expression of transcriptional regulators that progressively restrict cell potential to define ultimate neuronal identity and connectivity. In particular, establishment of sharp spatial boundaries and temporal transitions in gene expression is critical for correct neural patterning (<xref ref-type="fig" rid="fig2">Figures 2A</xref> and <xref ref-type="fig" rid="fig3">3A</xref>). Recently, it has been suggested that small non-coding RNAs termed microRNAs (miRNAs), which are generated by cytoplasmic RNaseIII Dicer, might play an important role in sharpening and consolidating these transitions through their ability to inhibit mRNA translation (<xref ref-type="bibr" rid="bib7">Bartel, 2018</xref>; <xref ref-type="bibr" rid="bib138">Wolter et al., 2017</xref>). It has been proposed that more than one-third of the genes in the human genome might be regulated by miRNAs (<xref ref-type="bibr" rid="bib78">Lewis et al., 2005</xref>). Interestingly, only a few examples of miRNA involvement in embryonic patterning and development have been reported thus far (<xref ref-type="bibr" rid="bib107">Rajman and Schratt, 2017</xref>). This scenario might be due to two constraints: 1) many miRNAs belong to large families, with individual members functioning redundantly; and 2) since miRNAs might function primarily to sharpen developmental transitions, their deficiency may not lead to overt deficits or phenotypic transformation but instead to more subtle defects affecting subsets of cells found at developmental boundaries.</p><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.50848.004</object-id><label>Figure 3.</label><caption><title>MicroRNA-mediated dorsoventral (DV) and rostrocaudal (RC) pattering of the spinal cord.</title><p>(<bold>A</bold>) In early embryonic stages (E8.5~E9), Nkx6.1 and Olig2 are co-expressed in a broad ventral domain spanning the prospective p3, pMN and part of the p2 domains. Subsequently, Nkx2.2 induced by sustained Shh signaling represses Olig2 in the p3 domain and <italic>miR-17â3p</italic> induced by Irx3 silences Olig2 in the p2 domain, forming the normal p2, pMN, and p3 progenitor domains. After MN generation, <italic>miR-218</italic> acts as a downstream effector of the Isl1-Lhx3 complex to establish and maintain MN identity. Among MN subtypes, <italic>miR-9</italic> seems to be involved in regulating MMC/LMC balance, whereas <italic>miR-17â¼92</italic> directly targets components of E3 ubiquitin ligases to impact subcellular localization of PTEN through monoubiquitination in the LMC-MNs. (<bold>B and C</bold>) <italic>Hoxa5</italic> transcription in progenitor cells fluctuates, and translation of fluctuating transcripts at this time propagates noise, leading to strong stochastic variability. Two critical coherent forward loops involving <italic>miR-27</italic> are capable of preventing precocious Hoxa5 protein expression, thereby maintaining the critically sharp boundary between Hoxa5 and Hoxc8 protein expression in embryonic spinal cords. <italic>Dicer</italic> <sup>nerualÎ</sup>: <italic>Sox1Cre<sup>+/-</sup>; Dicer <sup>floxed</sup></italic>, pMN: motor neuron progenitors, VZ: ventricular zone, IZ: intermediate zone, MZ: mantle zone. (<bold>D</bold>) MN-miRNA working models: <italic>miR-218</italic> is expressed in mature MNs to inhibit alternative neighboring genes. The potential <italic>miR-218</italic>-Slit-Robo autoregulatory loop is depicted. Subsequently, numbers of LMC motor neurons are reduced whereas MMC neurons are spared in <italic>Dicer <sup>MNÎ</sup></italic> and <italic>miR-17Â ~92 <sup>MNÎ</sup></italic> spinal cords. Whereas surviving caudal brachial LMC motor neurons in <italic>Dicer <sup>MNÎ</sup></italic> mutants correctly express Hoxc6 and Hoxc8 factors, expression of motor pool markers (i.e. Pea3, Scip, and Nkx6.1) is significantly eroded, resulting in near absence of defined motor pool subtype identity. The miRNA candidates needed to maintain motor pool identity have yet to be identified. (<bold>E</bold>) Illustration of how <italic>miR-17â¼92</italic> controls PTEN subcellular localization in developing LMC-MNs. This miRNA-mediated regulation modulates both target expression and target subcellular localization, providing LMC-MNs with an intricate defensive mechanism that controls their survival.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50848-fig3-v1.tif"/></fig><p>The developing spinal cord is an ideal system to uncover such subtle defects, as both the spatial and temporal boundaries that control cell specification in the ventral spinal cord, including for its spinal MNs, are well characterized (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Therefore, miRNAs have been shown to play critical roles in the spinal cord, from neuronal progenitor patterning to cell fate specification and survival (<xref ref-type="bibr" rid="bib3">Amin et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Chen et al., 2011</xref>; <xref ref-type="bibr" rid="bib18">Chen and Wichterle, 2012</xref>; <xref ref-type="bibr" rid="bib49">Haramati et al., 2010</xref>; <xref ref-type="bibr" rid="bib55">Hoye et al., 2017</xref>; <xref ref-type="bibr" rid="bib79">Li et al., 2017</xref>; <xref ref-type="bibr" rid="bib122">Thiebes et al., 2015</xref>; <xref ref-type="bibr" rid="bib127">Tung et al., 2015</xref>). During DV patterning in the ventral spinal cord, the bistable switches of transcriptional cross-repressive genetic loops are particularly critical for resolving cell identity at progenitor domain boundaries (<xref ref-type="bibr" rid="bib6">Balaskas et al., 2012</xref>; <xref ref-type="bibr" rid="bib60">Jukam and Desplan, 2010</xref>). Interestingly, lineage tracing experiments in which <italic>Cre</italic> recombinase was knocked into the domain-specific patterning genes <italic>Olig1</italic>, <italic>Olig2</italic> or <italic>Dbx1</italic> (<xref ref-type="bibr" rid="bib17">Chen et al., 2011</xref>; <xref ref-type="bibr" rid="bib28">Dessaud et al., 2010</xref>; <xref ref-type="bibr" rid="bib27">Dessaud et al., 2007</xref>; <xref ref-type="bibr" rid="bib141">Wu et al., 2006</xref>) revealed that each of these factors is transiently expressed in a broad ventral spinal region spanning three or more neighboring progenitor domains. Thus, somewhat different to the transitional view of the static cross-repressive loop mentioned above (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), the state of the cross-repressive genetic loops has to be malleable at the early developmental stage, and the initial broad expression of domain-specific determinants is then refined during development (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Repression of Olig2 in non-motor neuron progenitors appears to be partly achieved by temporal adaptation of spinal cells to Sonic hedgehog (Shh) signal. Clearance of Olig2 from the p3 domain (the most ventral neuronal progenitor domain) depends on induction of the repressor Nkx2.2 in response to sustained Shh signaling, whereas more passive loss of Olig2 expression in the p3 domain is proposed to be due to developmental de-sensitization of progenitors to the Shh signal (<xref ref-type="bibr" rid="bib28">Dessaud et al., 2010</xref>; <xref ref-type="bibr" rid="bib27">Dessaud et al., 2007</xref>; <xref ref-type="bibr" rid="bib141">Wu et al., 2006</xref>). In contrast, the p2 domain (the third neuronal progenitor domain from dorsal to ventral) utilizes a TF-miRNA loop to consolidate its plastic state. By disrupting miRNA biogenesis during simulated DV patterning of differentiating ES cells both in cellulo and in vivo, it was revealed that <italic>miR-17â3p</italic>, a member of the <italic>miR-17Â ~92</italic> cluster, is required to silence transient Olig2 expression in p2 progenitors (<xref ref-type="bibr" rid="bib17">Chen et al., 2011</xref>) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Thus, miRNA-mediated regulation of transcriptional programs might play a more general role in the refinement and positioning of spatial boundaries in developing neural tissue.</p><p>In addition to DV patterning in the neural tube, miRNAs also regulate the expression of TFs to fine-tune RC pattering of the spinal cord. Initial RC patterning of the neural tube leads to differential expression of <italic>Hox</italic> genes that contribute to the specification of MN subtype identity. <italic>Hox</italic> genes are clustered in genome loci that also contain miRNAs, including <italic>miR-10</italic> and <italic>miR-196</italic>. Intriguingly, <italic>Hox</italic> cluster-embedded miRNAs preferentially target <italic>Hox</italic> mRNAs (<xref ref-type="bibr" rid="bib145">Yekta et al., 2008</xref>). Moreover, the <italic>Hox-</italic>cluster miRNAs are predominantly targeted to 3â² <italic>Hox</italic> (<italic>Hox</italic> 1Â ~Â 6) genes to ensure âposterior prevalenceâ (<xref ref-type="bibr" rid="bib145">Yekta et al., 2008</xref>). In the developing spinal cord of chick embryos, specific timing of <italic>miR-196</italic> expression is required for proper MN differentiation, which is mediated by downregulation of <italic>Hoxb8</italic>. Failure to clear Hoxb8 in a spatial and temporal manner abolishes MN generation (<xref ref-type="bibr" rid="bib5">Asli and Kessel, 2010</xref>). This result highlights that both the spatial distribution and timing of Hox expression are pivotal for MN subtype diversification (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Coincidentally, although several <italic>Hox</italic> mRNAs, including <italic>Hoxa5</italic> and <italic>Hoxc6</italic>, are expressed in MN progenitors in a ânoisyâ manner, the respective Hox proteins are not expressed in these progenitors and only become detectable in postmitotic MNs (<xref ref-type="bibr" rid="bib21">Dasen et al., 2005</xref>; <xref ref-type="bibr" rid="bib79">Li et al., 2017</xref>). In conditional neural <italic>Dicer</italic> mutants (<italic>Sox1-Cre; Dicer<sup>floxed</sup></italic>, <italic>Dicer <sup>NeuralÎÂ </sup></italic>)Â in which all mature miRNA production is abrogated in the CNS, Hoxa5 protein is precociously expressed at progenitors and the Hox5/8 boundary is expanded caudally, both in cellulo and in vivo (<xref ref-type="fig" rid="fig3">Figure 3B</xref>) (<xref ref-type="bibr" rid="bib79">Li et al., 2017</xref>). Using <italic>in silico</italic> simulation, two feed-forward Hox-miRNA loops have been uncovered that account for the precocious and noisy Hoxa5 expression, as well as the ill-defined boundary phenotype of <italic>Dicer</italic> mutants. In this scenario, <italic>miR-27</italic> appears to be a major regulator coordinating the temporal delay and spatial boundary of Hox protein expression. This Hox-miRNA circuit filters transcription noise and controls the timing of protein expression to confer robust individual MN identity (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Thus, a miRNA-mediated mechanism regulating DV and RC patterning of the spinal cord provides two additional functional tuning mechanisms for establishing cell fate in MNs: 1) the coherent TF-miRNA feed-forward loop defines plastic cell fate at the early patterning stage to allow precise cell fate determination later (i.e., the Olig2/Irx3/<italic>miR-17â3p</italic> and Hoxc8/Hoxa5/<italic>miR-27</italic> loops); and 2) the retinoic acid-miRNA feed-forward loop is important for inhibiting fluctuations in Hox miRNA expression in the progenitors, as precocious protein expression at this stage may amplify stochastic effects, leading to noisy protein levels. This combined model represents a powerful strategy for achieving the precision and robustness of morphogen-mediated pattern formation (<xref ref-type="fig" rid="fig3">Figure 3C</xref>).</p><p>In addition to the role of miRNAs during neural progenitor patterning, miRNAs also play critical functions in postmitotic MNs. In the developing spinal cord, expression of <italic>miR-218</italic> is directly upregulated by the Isl1-Lhx3 complex to drive MN fate (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Loss of <italic>miR-218</italic> function leads to impaired generation of generic MNs, suggesting that this miRNA plays a crucial role in MN differentiation (<xref ref-type="bibr" rid="bib3">Amin et al., 2015</xref>; <xref ref-type="bibr" rid="bib122">Thiebes et al., 2015</xref>). Furthermore, mutant mice lacking <italic>miR-218</italic> die neonatally and exhibit neuromuscular junction defects, MN hyperexcitability, and progressive MN degeneration, recapitulating traits of motor neuron disease (<xref ref-type="bibr" rid="bib3">Amin et al., 2015</xref>). These two studies highlight the predominant role of <italic>miR-218</italic> in mature MNs. However, <italic>miR-218</italic> does not seem to exert its functions by targeting a few specific genes. Instead, it appears to repress an array of transcripts in the alternative neighboring interneuron genes to maintain postmitotic MN cell fate and robust neuromuscular functions (<xref ref-type="bibr" rid="bib3">Amin et al., 2015</xref>; <xref ref-type="bibr" rid="bib122">Thiebes et al., 2015</xref>) (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Interestingly, <italic>miR-218</italic> is encoded by an intron of the extracellular matrix <italic>Slit2</italic> and <italic>Slit3</italic> genes and it inhibits expression of neural cell adhesion molecules Robo1 and Robo2 and multiple components of the heparan sulfate biosynthetic pathway responsible for normal vascularization of the retina (<xref ref-type="bibr" rid="bib112">Small et al., 2010</xref>). Given that recent evidence indicates that the function of the Slit-Robo regulatory axis is also important for proper positioning of MNs and their exit points (<xref ref-type="bibr" rid="bib67">Kim et al., 2019</xref>), it would be interesting to investigate if the <italic>miR-218</italic>-Slit-Robo autoregulatory loop is also important for MN axon pathfinding and targeting (<xref ref-type="fig" rid="fig3">Figure 3D</xref>).</p><p>Do miRNAs also play a role in postmitotic MN subtype diversification? Postmitotic MNs are diversified along the RC axis of the spinal cord to innervate corresponding target muscles. This process primarily relies on a regulatory network of Hox-TFs that translate neuronal identity into patterns of connectivity. Foxp1 is a crucial determinant of MN diversification and connectivity, interpreting the Hox regulatory network to control the formation of a topographic neural map. Although Hox/Foxp1 TFs have been recognized as principal regulators of subtype specification, a role for posttranscriptional regulation is also recognized. For instance, <italic>miR-9</italic> is transiently expressed in Foxp1<sup>on</sup> LMC regions. Overexpression or knockdown of <italic>miR-9</italic> alters MN subtypes, switches columnar identities, and changes axonal innervations in developing chick spinal cords. <italic>miR-9</italic> modifies spinal columnar organization by specifically regulating Foxp1 protein levels, which in turn determine distinct MN subtypes (<xref ref-type="bibr" rid="bib102">Otaegi et al., 2011</xref>) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Additionally, deletion of the enzyme Dicer from all MNs using Olig2-Cre (<italic>Dicer <sup>MNÎÂ </sup></italic>) revealed a preferential loss of many limb- and sympathetic ganglia-innervating spinal MNs (<xref ref-type="bibr" rid="bib18">Chen and Wichterle, 2012</xref>). Furthermore, this disruption also led to defects in motor pool identity specification, yet the miRNA candidates to maintain motor pool identity have yet to be unveiled (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). These results indicate that miRNAs are an integral part of the genetic program controlling MN survival and acquisition of subtype-specific properties. Subsequent study uncovered that the <italic>miR-17Â ~92</italic> cluster is highly enriched in LMC-MNs. Furthermore, conditional MN <italic>miR-17Â ~92</italic> deletion (<italic>mi-17Â ~92 <sup>MNÎÂ </sup></italic>) resulted in selective cell death of LMC-MNs. Mechanistically, <italic>mir-17Â ~92</italic> not only suppresses PTEN expression, but also independently attenuates accumulation of nuclear PTEN, with this latter being a more potent apoptosis stimulator (<xref ref-type="bibr" rid="bib127">Tung et al., 2015</xref>) (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Tellingly, reduced <italic>miR-17Â ~92</italic> is accompanied by elevated nuclear PTEN in the spinal MNs of presymptomatic <italic>SOD1<sup>G93A</sup></italic> mice, thatÂ is the most common mouse strain used as an ALS disease model. Selective dysregulation of the <italic>miR-17Â ~92</italic>/nuclear PTEN axis in degenerating <italic>SOD1<sup>G93A</sup></italic> LMC-MNs has been demonstrated in a double-transgenic embryonic stem cell system and, moreover, was recapitulated in human <italic>SOD1<sup>+/L144F</sup></italic> induced pluripotent stem cell (iPSC)-derived MNs. Furthermore, overexpression of <italic>miR-17Â ~92</italic> significantly rescues human <italic>SOD1<sup>+/L144F</sup></italic> MNs, and intrathecal delivery of scAAV9 [self-complementary adeno-associated viral serotype 9]-<italic>miR-17Â ~Â 92</italic> improves motor deficits and survival in <italic>SOD1<sup>G93A</sup></italic> mice (<xref ref-type="bibr" rid="bib128">Tung et al., 2019</xref>). Therefore, <italic>miR-17Â ~92</italic> either controls LMC-MN survival during embryonic development or confers MN subtype differential resistance to ALS-associated degeneration. Thus, similar to TFs, miRNAs contribute to neuronal progenitor patterning, cell fate specification, and long-term survival during MN differentiation (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><table-wrap id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.50848.005</object-id><label>Table 1.</label><caption><title>Proposed functions of microRNAs during spinal motor neuron (sMN) development</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">miRNA</th><th valign="top">Proposed roles in sMNs</th><th valign="top">Targets/interaction</th><th valign="top">Organism/cell models</th><th valign="top">Methods of genetic analyses</th><th valign="top">References</th></tr></thead><tbody><tr><td valign="top"><italic>miR-9</italic></td><td valign="top"><italic>miR-9</italic> promotes the switch from early-born to late-born motor neuron populations as well as MMC/LMC subtypes</td><td valign="top"> <italic>Foxp1</italic></td><td valign="top">Chicken</td><td valign="top">transient decoy of <italic>miR-9</italic> and overexpression of <italic>miR-9</italic> in ovo</td><td valign="top">(<xref ref-type="bibr" rid="bib87">Luxenhofer et al., 2014</xref>; <xref ref-type="bibr" rid="bib102">Otaegi et al., 2011</xref>)</td></tr><tr><td valign="top"><italic>miR-17Â ~Â 92</italic></td><td valign="top">1. <italic>miR-17â3p</italic> carves p2/pMN boundary at progenitor stage <break/>2. <italic>miR-17Â ~Â 92</italic> governs LMC-MN survival during development and degeneration in ALS</td><td valign="top"><italic>Olig2</italic> <break/><italic>PTEN/Ndfip1/Nedd4-2</italic></td><td valign="top">Mouse <break/>Mouse/human induced pluripotent stem cells</td><td valign="top"><italic>CAGGS:Cre<sup>ER</sup>; Dicer <sup>floxed</sup></italic> and <italic>miR-17Â ~Â 92<sup>-/-</sup></italic> embryos <break/><italic>Olig2:Cre; miR-17Â ~Â 92 <sup>floxed</sup></italic> embryos and <italic>miR-17Â ~Â 92</italic> overexpression in human ALS-iPSC derived MNs</td><td valign="top">(<xref ref-type="bibr" rid="bib17">Chen et al., 2011</xref>) <break/>(<xref ref-type="bibr" rid="bib127">Tung et al., 2015</xref>; <xref ref-type="bibr" rid="bib128">Tung et al., 2019</xref>)</td></tr><tr><td valign="top"><italic>miR-27</italic></td><td valign="top"><italic>miR-27</italic> filters Hox temporal transcription noise to confer boundary formation in the spinal cord</td><td valign="top"><italic>Hoxa5</italic></td><td valign="top">Mouse and chicken</td><td valign="top"><italic>Sox1:Cre; Dicer <sup>floxed</sup></italic>, transient decoy of <italic>miR-27</italic> in ovo, and <italic>mir-23Â ~Â 27Â ~Â 24<sup>-/-</sup></italic> embryos</td><td valign="top">(<xref ref-type="bibr" rid="bib79">Li et al., 2017</xref>)</td></tr><tr><td valign="top"><italic>miR-196</italic></td><td valign="top"><italic>miR-196</italic> confines the rostrocaudal axis in the neural tube</td><td valign="top"><italic>Hoxb8</italic></td><td valign="top">Chicken</td><td valign="top">Transient decoy of <italic>miR-196</italic> in ovo</td><td valign="top">(<xref ref-type="bibr" rid="bib5">Asli and Kessel, 2010</xref>)</td></tr><tr><td valign="top"><italic>miR-218</italic></td><td valign="top"><italic>miR-218</italic> defines a neuronal gene network that is selectively tuned down in MNs to prevent neuromuscular failure and neurodegeneration.</td><td valign="top">Progenitor genes (<italic>Sox21</italic>, <italic>Tead1</italic>, etc.) <break/>Neighboring genes (<italic>Slc6a1</italic>, <italic>Bcl11a</italic>, <italic>Foxp2</italic>, etc.)</td><td valign="top">Mouse and chicken</td><td valign="top">Transient decoy of <italic>miR-218</italic> in ovo and <italic>miR-218<sup>-/-</sup></italic> embryos</td><td valign="top">(<xref ref-type="bibr" rid="bib3">Amin et al., 2015</xref>; <xref ref-type="bibr" rid="bib122">Thiebes et al., 2015</xref>)</td></tr></tbody></table></table-wrap></sec><sec id="s3"><title>MicroRNAs during motor neuron degeneration in SMA</title><p>Given by the versatile roles of miRNAs in regulating MN differentiation mentioned above, it is not surprising that miRNA dysregulation has been increasingly linked to MN-associated degeneration diseases, such as ALS and SMA. ALS-linked miRNAs have been intensively studied and elegantly reviewed elsewhere (<xref ref-type="bibr" rid="bib33">Eitan and Hornstein, 2016</xref>; <xref ref-type="bibr" rid="bib34">Emde et al., 2015</xref>). However, the role of miRNAs in SMA is just beginning to emerge. A detailed list of miRNAs implicated in SMA has been reviewed recently (<xref ref-type="bibr" rid="bib88">Magri et al., 2018</xref>), which we summarize in <xref ref-type="table" rid="table2">Table 2</xref>. Here, we focus our discussion on some of the most recent studies linking specific miRNAs (i.e., <italic>miR-2</italic>, <italic>miR-146a</italic>, and <italic>miR-23a</italic>) to SMA pathogenesis and the potential of miRNAs as biomarkers and therapeutic targets.</p><table-wrap id="table2" position="float"><object-id pub-id-type="doi">10.7554/eLife.50848.006</object-id><label>Table 2.</label><caption><title>Proposed spinal muscular atrophy (SMA)-microRNA relationships</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">miRNA</th><th valign="top">Role in MN disease</th><th valign="top">Targets</th><th valign="top">Organism/cell models and expression profiles</th><th valign="top">Findings and proposed mechanism of SMA pathogenesis</th><th valign="top">References</th></tr></thead><tbody><tr><td valign="top"><italic>miR-2</italic></td><td valign="top">Neuronal development and function; correct NMJ functioning</td><td valign="top">CHRM2, m2R</td><td valign="top"><italic>C. elegans</italic> model, <break/>SMA mouse model. <break/>Decreased</td><td valign="top">Alters NMJ function</td><td valign="top">(<xref ref-type="bibr" rid="bib101">O'Hern et al., 2017</xref>)</td></tr><tr><td valign="top"><italic>miR-9Â </italic><sup>(1)</sup></td><td valign="top">MN dendritic outgrowth and synaptic function</td><td valign="top">Neurofilament heavy subunit (NEFH), REST, Map1b, MCPIP1</td><td valign="top">Mouse, patient fibroblasts, patient serum. <break/>Decreased in spinal cord, but increased in skeletal muscle</td><td valign="top">Dysregulated expression in MNs differentiated from ESCs. Regulation of MN subtype determination (FOXP1). <break/>miR-9 can delay neurite outgrowth in vitro and impair radial neuronal migration in embryonic mouse neocortex in vivo.</td><td valign="top">(<xref ref-type="bibr" rid="bib13">Catapano et al., 2016</xref>; <xref ref-type="bibr" rid="bib49">Haramati et al., 2010</xref>)</td></tr><tr><td valign="top"><italic>miR-23a</italic></td><td valign="top">Neuroprotective properties; regulate axonal development; suppress skeletal muscle atrophy</td><td valign="top">Atrogin1, MuRF1 (maybe, no direct target experiment was verified by luciferase assay)</td><td valign="top">Patient induced pluripotent stem cells, <break/>SMA mouse model. <break/>Decreased</td><td valign="top"><italic>miR-23a</italic> can prevent the astrocyte-conditioned media-induced MNÂ loss in vitro. <break/>In mice model, enhanced <italic>miR-23a</italic> expression via virus vector increased MN soma size and muscle fiber area, and reduced NMJ defects</td><td valign="top">(<xref ref-type="bibr" rid="bib62">Kaifer et al., 2019</xref>)</td></tr><tr><td valign="top"><italic>miR-100â5p</italic></td><td valign="top">Abnormal proliferation of neural progenitors; aberrant cell cycle</td><td valign="top">Potentially insulin-like growth factor one receptor (IGF1R)</td><td valign="top">SMNâ7 mouse neural stem cells from spinal cord. <break/>Decreased</td><td valign="top">Decreased <italic>miR-100â5p</italic> in SMAÎ7 mice neural stem cells induces high IGF1R, excessive proliferation of neural progenitors, and prevents appropriate exit of the cell cycle.</td><td valign="top">(<xref ref-type="bibr" rid="bib85">Luchetti et al., 2015</xref>)</td></tr><tr><td valign="top"><italic>miR-132</italic> (possible)</td><td valign="top">Neuron dendritic outgrowth and synaptic plasticity; neovascularization, may cause ischemic pathology in both skeletal muscle and spinal cord of SMA model</td><td valign="top">Dysregulated expression due to TDP43 interaction with Dicer (amyotrophic lateral sclerosis data), p250GAP</td><td valign="top">SMA mice, patient serum. <break/>Decreased in spinal cord, but increased in skeletal muscle</td><td valign="top">Expression is dysregulated in TDP-43-deficient amyotrophic lateral sclerosis (ALS). <break/>Neuronal morphology and cognition in ALS. <break/><italic>miR-132</italic> can delay neurite outgrowth in vitro and impair radial neuronal migration in embryonic mouse neocortex in vivo. <break/>Involved in synaptic plasticity. <break/>Process of neovascularization. Recent reports have highlighted vascular defects in both skeletal muscle and spinal cord of SMA patients.</td><td valign="top">(<xref ref-type="bibr" rid="bib13">Catapano et al., 2016</xref>)</td></tr><tr><td valign="top"><italic>miR-146</italic></td><td valign="top">MN loss caused by astrocyte-mediated pathology through NFÎºB signaling</td><td valign="top">GDNF, NOTCH2, GATA transcription factors</td><td valign="top">Patient induced pluripotent stem cells. <break/>Increased</td><td valign="top"><italic>miR-146</italic> levels are influenced both directly and indirectly by SMN1 levels. SMN re-expression decreases <italic>miR-146a</italic> levels nearly to control levels. <break/>The NFÎºB pathway is an inducer of <italic>miR-146a</italic>.</td><td valign="top">(<xref ref-type="bibr" rid="bib111">Sison et al., 2017</xref>)</td></tr><tr><td valign="top"><italic>miR-183</italic></td><td valign="top">Protein synthesis; axonal outgrowth</td><td valign="top">mTOR pathway</td><td valign="top">Mouse, cortical neurons, patient fibroblasts. <break/>Increased</td><td valign="top">Increased <italic>miR-183</italic> and reduced local axonal translation of mTOR in SMN-deficient neurons.</td><td valign="top">(<xref ref-type="bibr" rid="bib70">Kye et al., 2014</xref>)</td></tr><tr><td valign="top"><italic>miR-206Â </italic><sup>(2)</sup> <break/>(muscle-specific)</td><td valign="top">Myofiber formation; satellite cell differentiation; neuroprotective role in re-innervation of muscle endplates after acute nerve injury</td><td valign="top">Axis of HDAC4-FGFBP1, <break/>Pola1, BDNF</td><td valign="top">SMA mouse, patient serum. <break/>Increased in both spinal cord and skeletal muscle</td><td valign="top">Endogenously increased <italic>miR-206</italic>, with HDAC4 protein reduction and increased <italic>FGFBP1</italic> mRNA, activates neuroprotective mechanism in muscle cells to increase re-innervation of muscle endplates.</td><td valign="top">(<xref ref-type="bibr" rid="bib13">Catapano et al., 2016</xref>; <xref ref-type="bibr" rid="bib129">Valsecchi et al., 2015</xref>)</td></tr><tr><td valign="top"><italic>miR-335â5p</italic></td><td valign="top">Control of differentiation or self-renewal of mouse ESCs</td><td valign="top">MEST, OCT4, RB1</td><td valign="top">SMNâ7 mouse neural stem cells, human induced pluripotent stem cells. <break/>Decreased</td><td valign="top">Possible epigenetic regulation through methylation to affect cell differentiation.</td><td valign="top">(<xref ref-type="bibr" rid="bib85">Luchetti et al., 2015</xref>; <xref ref-type="bibr" rid="bib97">Murdocca et al., 2016</xref>)</td></tr><tr><td valign="top"><italic>miR-375</italic></td><td valign="top">Neurogenesis and protects neurons from apoptosis in response to DNA damage.</td><td valign="top">P53, PAX6, CCND2</td><td valign="top">Human neural progenitor cell cultures. <break/>Decreased</td><td valign="top">MNs from an SMA patient have shown reduced levels of <italic>miR-375</italic>, elevated p53 protein levels, and higher susceptibility to DNA damage-induced apoptosis.</td><td valign="top">(<xref ref-type="bibr" rid="bib10">Bhinge et al., 2016</xref>)</td></tr><tr><td valign="top"><italic>miR-431</italic></td><td valign="top">Regulation of motor neuron axon neurite outgrowth</td><td valign="top">Chondrolectin (Chodl): a type one transmembrane protein and member of the c-type lectin domain-containing family</td><td valign="top">Mouse MN culture, patient fibroblasts/induced pluripotent stem cells. <break/>Increased</td><td valign="top">Increased <italic>miR-431</italic> regulates motor neuron neurite length by targeting chondrolectin involved in motor neuron axon outgrowth.</td><td valign="top">(<xref ref-type="bibr" rid="bib136">Wertz et al., 2016</xref>)</td></tr></tbody></table><table-wrap-foot><fn><p><sup>1Â </sup><italic>miR-9</italic>/<italic>9*</italic> is another microRNA potentially implicated in motor neuron disease. It has been linked to the loss of spinal motor neurons that leads to SMA.</p><p><sup>2Â </sup>Since <italic>miR-206</italic> is required for efficient regeneration of neuromuscular synapses after acute nerve injury, this scenario probably accounts for its salutary effects in SMA.</p></fn></table-wrap-foot></table-wrap><p>SMA is an autosomal recessive neurodegenerative disease characterized by devastating muscular atrophy attributable to progressive spinal MN degeneration. Although SMA is a relatively rare disease, with an estimated worldwide incidence of one in 6,000Â ~Â 10,000 newborns, it is notable that SMA is the second most common autosomal recessive disease after cystic fibrosis and is the most common monogenic defect leading to infant mortality (<xref ref-type="bibr" rid="bib86">Lunn and Wang, 2008</xref>). SMA is caused by reduced levels of the 38 kDa <underline>S</underline>urvival <underline>M</underline>otor <underline>N</underline>euron (SMN) protein due to deletion or mutation of the <italic>Survival of Motor Neuron 1</italic> (<italic>SMN1</italic>) gene. In humans, SMN protein is actually encoded by two genes: <italic>SMN1</italic> and highly homologous <italic>SMN2</italic>, which essentially differs by one nucleotide (CâT) in exon 7. This critical difference results in preferential exclusion of exon seven from most <italic>SMN2</italic> transcripts, termed SMNâ³7. As a consequence, <italic>SMN2</italic> generatesÂ ~10% of full-length (FL) SMN mRNAs and their product-functional SMN proteins (<xref ref-type="bibr" rid="bib12">Burghes and Beattie, 2009</xref>). As these FL-<italic>SMN2</italic> transcripts can partially compensate for loss of <italic>SMN1</italic>, it is reasoned that the FL-<italic>SMN2</italic> transcript copy number may determine phenotypic severity in SMA patients. Therefore, SMA is caused by loss of the <italic>SMN1</italic> gene and disease manifestation is partially reflected by the degree of <italic>SMN2</italic> gene compensation (<xref ref-type="bibr" rid="bib12">Burghes and Beattie, 2009</xref>). However, recent studies have indicated that additional modifiers might also be involved in modulating SMA clinical severity (<xref ref-type="bibr" rid="bib19">Crawford et al., 2012</xref>).</p><p>SMN is ubiquitously expressed in almost all kinds of somatic cells, with a distribution in both the cytoplasm and nucleus (<xref ref-type="bibr" rid="bib12">Burghes and Beattie, 2009</xref>). Notably, the most appreciated canonical role of SMN is to serve as an essential ribonucleoprotein (RNP) for mRNA splicing. SMN protein is embedded in a complex with seven Gemins and UNR-interacting protein (UNRIP) that loads Sm protein onto nascent uridine-rich noncoding RNAs (U-snRNAs) upon their export to the cytoplasm, thereby creating small nuclear RNPs (snRNPs) that form spliceosomes in the nucleus (<xref ref-type="bibr" rid="bib12">Burghes and Beattie, 2009</xref>; <xref ref-type="bibr" rid="bib30">Dostie et al., 2003</xref>). In addition to facilitating snRNP assembly, the SMN complex has a role in assisting arginine methylation of some splicing-related proteins that are involved in pre-mRNA splicing (<xref ref-type="bibr" rid="bib90">Meister and Fischer, 2002</xref>; <xref ref-type="bibr" rid="bib104">Pellizzoni et al., 2002</xref>). Studies on SMA animal models have also revealed a direct correlation between the ability to assemble snRNPs and SMA phenotypes, and delivery of mature snRNPs even without the SMN component is sufficient to rescue SMA phenotypes (<xref ref-type="bibr" rid="bib41">Gabanella et al., 2007</xref>; <xref ref-type="bibr" rid="bib137">Winkler et al., 2005</xref>; <xref ref-type="bibr" rid="bib140">Workman et al., 2009</xref>). This outcome implies that SMN protein levels might affect splicing of SMN pre-mRNA to include exon seven through an autoregulatory loop, thereby influencing a general process of snRNP biogenesis (<xref ref-type="bibr" rid="bib59">Jodelka et al., 2010</xref>). In addition to the canonical role of SMN protein in the splicing machinery, some studies have also highlighted the multilayer functions of SMN. For example, assembly of SMN protein is also involved in a number of essential cellular pathways, including DNA repair and protein/mRNA transportation along MN axons (<xref ref-type="bibr" rid="bib29">Donlin-Asp et al., 2016</xref>; <xref ref-type="bibr" rid="bib36">Fallini et al., 2012</xref>; <xref ref-type="bibr" rid="bib98">Murray et al., 2015</xref>; <xref ref-type="bibr" rid="bib126">Tu et al., 2017</xref>). Collectively, studies to date support that loss of SMN-RNP complex assembly and its activity results in a series of different cellular pathways that lead to SMA. However, it is still unclear if SMA pathology is due to a particularly vulnerable pathway or a combination of dysregulated effects. In addition, it is still unclear how a deficiency in ubiquitously expressed SMN can result in selective MN degeneration.</p><p>Deletion of the miRNA biogenesis enzyme Dicer in MNs either using Olig2-Cre or ChAT-Cre results in MN degeneration that mimics certain hallmarks of SMA and ALS (<xref ref-type="bibr" rid="bib18">Chen and Wichterle, 2012</xref>; <xref ref-type="bibr" rid="bib49">Haramati et al., 2010</xref>; <xref ref-type="bibr" rid="bib128">Tung et al., 2019</xref>). Large-scale miRNA profiling platforms have identified miRNAs that are significantly dysregulated in MN disease. Dysregulated MN-specific miRNAs are potential culprits in spinal MN mortality. In this scenario, some important developmentally-regulated (i.e. <italic>miR-9Â </italic>andÂ <italic>miR-133</italic>) and MN-enriched miRNAs (i.e. <italic>miR-218</italic> and <italic>miR-17Â ~92</italic>) have been implicated as being important for SMA and/or ALS onset or progression (<xref ref-type="bibr" rid="bib3">Amin et al., 2015</xref>; <xref ref-type="bibr" rid="bib55">Hoye et al., 2017</xref>; <xref ref-type="bibr" rid="bib71">Kye and GonÃ§alves, 2014</xref>; <xref ref-type="bibr" rid="bib127">Tung et al., 2015</xref>; <xref ref-type="bibr" rid="bib128">Tung et al., 2019</xref>). Furthermore, other neuronal-enriched miRNAs also seem to be involved in spinal diseases, such as <italic>miR-21</italic>/<italic>miR-431</italic>/<italic>miR-138</italic> for axonal regeneration of sensory neurons or <italic>miR-196a</italic> in spinal and bulbar muscular atrophy (SBMA) (<xref ref-type="bibr" rid="bib81">Liu et al., 2013</xref>; <xref ref-type="bibr" rid="bib94">Miyazaki et al., 2012</xref>; <xref ref-type="bibr" rid="bib115">Strickland et al., 2011</xref>; <xref ref-type="bibr" rid="bib142">Wu and Murashov, 2013</xref>). These findings raise the possibility that miRNAs might serve as: 1) important regulators of SMN-mediated pathways; and 2) potential markers reflecting SMA pathology.</p><p>Despite this evidence of a role for miRNAs in SMA disease progression, it remains unclear if dysregulated miRNAs are the direct pathogenic cause or a consequence of SMA progression. Given that SMN protein per se does not contain known RNA- or miRNA-binding domains (<xref ref-type="bibr" rid="bib9">Bertrandy et al., 1999</xref>; <xref ref-type="bibr" rid="bib108">Ravanidis et al., 2018</xref>), the SMN protein complex might instead interact with the miRNA biogenesis pathway to regulate miRNA production (<xref ref-type="bibr" rid="bib108">Ravanidis et al., 2018</xref>). For example, Gemin3 and Gemin4 of the SMN complex can assemble with a number of miRNAs to form a miRNA-binding RNP (miRNP) (<xref ref-type="bibr" rid="bib30">Dostie et al., 2003</xref>; <xref ref-type="bibr" rid="bib96">Mourelatos et al., 2002</xref>) (<xref ref-type="fig" rid="fig4">Figure 4</xref>). This miRNP complex can further bind to Argonaute 2 (AGO2) that functions as a core protein in the RNA-induced silencing complex (RISC) mediating miRNA biogenesis as well as mRNA posttranscriptional regulation (<xref ref-type="bibr" rid="bib15">Cauchi, 2010</xref>). Yet SMN does not seem to bind to miRNP directly, if the miRNP is functionally important in SMA pathology still needs to be further investigated. Interestingly, in addition to the role of SMN in RNA processing, recent studies have uncovered unexpected interactions of SMN with miRNA biogenesis proteins including fragile X mental retardation protein (FMRP), KHâtype splicing regulatory protein (KSRP) and fused in sarcoma/translocated in liposarcoma (FUS/TLS) (<xref ref-type="bibr" rid="bib106">Piazzon et al., 2008</xref>; <xref ref-type="bibr" rid="bib117">Sun et al., 2015</xref>; <xref ref-type="bibr" rid="bib119">Tadesse et al., 2008</xref>; <xref ref-type="bibr" rid="bib144">Yamazaki et al., 2012</xref>) (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Thus, SMN is engaged in miRNAâRBP complexes and likely regulates miRNA biogenesis and metabolism. Deficiency of SMN may alter MN-specific miRNAs or miRNPs, resulting in MN death (<xref ref-type="bibr" rid="bib15">Cauchi, 2010</xref>; <xref ref-type="bibr" rid="bib99">Nelson et al., 2004</xref>). In <xref ref-type="table" rid="table3">Table 3</xref>, we list SMN-associated RBPs and their roles in miRNA biogenesis and functions. In <xref ref-type="fig" rid="fig4">Figure 4</xref>, we illustrate potential mechanisms by which SMN interacts with various RBPs to regulate miRNA biogenesis and function. In summary, the proposed mechanisms by which SMN-associated RBPs might be involved in miRNA biogenesis include: (1) facilitating recruitment of Drosha to specific miRNAs; (2) binding to components of the Drosha and Dicer complexes; (3) acting as regulators to RISC complex (<xref ref-type="bibr" rid="bib37">Fallini et al., 2014</xref>; <xref ref-type="bibr" rid="bib45">GonÃ§alves et al., 2018</xref>; <xref ref-type="bibr" rid="bib108">Ravanidis et al., 2018</xref>). Consequently, alteration of the SMN-RBP complex caused by SMN deficiency in the SMA pathological background might lead to dysregulated processing of miRNAs and pre-mRNA splicing. Identification of SMN-associated RBPs involved in transport and processing of different miRNAs could help explain SMA pathogenesis and reveal novel therapeutic targets.</p><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.50848.007</object-id><label>Figure 4.</label><caption><title>Potential involvement of SMN RNA-binding proteins (RBPs) in regulating microRNA biogenesis and function.</title><p>During the first step of miRNA biogenesis in the nucleus, pri-miRNA is processed by a microprocessor complex comprising Drosha and DiGeorge syndrome chromosomal region 8 (DGCR8) to produce hairpin-shaped pre-miRNA. Pre-miRNA is then exported to the cytoplasm by exportin-5 and further cleaved by Dicer. During nuclear and cytoplasmic processing of primary and precursor levels of miRNA, several RBPsâincluding TAR DNA-Binding Protein 43 (TDP-43), fused sarcoma/translocated in liposarcoma (FUS/TLS), KH-type splicing regulatory protein (KSRP), and Fragile X mental retardation protein (FMRP)â are known to link the SMN complex to the Drosha/DGRC8 complex and/or Dicer. Subsequently, the miRNA duplex is unwound into a single strand that is then loaded into argonaute proteins (AGO) to form the RNA-induced silencing complex (RISC). The miRNA-RISC complex plays a crucial role in post-transcriptional repression of target mRNA expression. Notably, during maturation and action of functional miRNAs either in the cytoplasm or nucleus, the SMN complex is known to interact with several RBPs including FMRP, HuD, and insulin-like growth factor 2Â mRNA-binding protein 1 (IMP1). However, it remains to be established if SMN-RBP is involved in miRNA-mediated silencing.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-50848-fig4-v1.tif"/></fig><table-wrap id="table3" position="float"><object-id pub-id-type="doi">10.7554/eLife.50848.008</object-id><label>Table 3.</label><caption><title>Proposed SMN-associated RNA-binding proteins involved in microRNA pathways.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">SMN-associated RBPs</th><th valign="top">RBP interaction assay</th><th valign="top">General functions in posttranscriptional regulation of mRNA</th><th valign="top">Proposed roles in miRNA metabolism/processing</th><th valign="top">Neuronal modeling mechanism</th><th valign="top">References</th></tr></thead><tbody><tr><td valign="top">TAR DNA-binding protein-43 <break/>(TDP-43)<sup>a,b</sup></td><td valign="top">FLAG-Drosha or FLAG-TDP-43 interacts in nuclear extracts from HEK293T cells. Partial colocalization of TDP-43 and SMN in MNs.</td><td valign="top">Transcriptional regulation, pre-mRNA splicing, mRNA transport and translation</td><td valign="top">1. Integrating with the Dicer and Drosha complexes <break/>2. Regulating pre-miRNA biogenesis</td><td valign="top">Neuron differentiation, neuronal plasticity, synapse formation, neurite outgrowth</td><td valign="top">(<xref ref-type="bibr" rid="bib65">Kawahara and Mieda-Sato, 2012</xref>; <xref ref-type="bibr" rid="bib135">Wang et al., 2002</xref>)</td></tr><tr><td valign="top">Fused sarcoma/translocated in liposarcoma (FUS/TLS)<sup>a,c</sup></td><td valign="top">IP and GST pulldown SMN in HeLa nuclear extracts and mouse neuroblastoma (N2a) using FUS antibody.</td><td valign="top">Transcriptional regulation, pre-mRNA splicing, mRNA transport and translation</td><td valign="top">Recruiting the Drosha complex</td><td valign="top">Synapse formation, neuronal plasticity, neurite outgrowth, neuronal differentiation and proliferation</td><td valign="top">(<xref ref-type="bibr" rid="bib95">Morlando et al., 2012</xref>; <xref ref-type="bibr" rid="bib117">Sun et al., 2015</xref>; <xref ref-type="bibr" rid="bib144">Yamazaki et al., 2012</xref>)</td></tr><tr><td valign="top">Fragile X mental retardation protein (FMRP)</td><td valign="top">IP and GST pulldown SMN complex in human neuroblastoma SH-SY5Y cells using FLAG-tagged FMRP antibody. <break/>IP antibodies specific to human FMRP were used to pull down Dicer and associated miRNAs in an EBV-transformed human B cell line. IP was performed from total HeLa cell lysates with a monoclonal antibody to eIF2C2.</td><td valign="top">mRNA stability, translation inhibition</td><td valign="top">Integrating with AGO and Dicer in RNA-induced silencing complex (RISC)<sup>d</sup></td><td valign="top">Synapse formation, neuronal plasticity, neurite outgrowth, neuronal differentiation and proliferation</td><td valign="top">(<xref ref-type="bibr" rid="bib32">Edbauer et al., 2010</xref>; <xref ref-type="bibr" rid="bib58">Jin et al., 2004</xref>; <xref ref-type="bibr" rid="bib106">Piazzon et al., 2008</xref>)</td></tr><tr><td valign="top">KH-type splicing regulatory protein (KSRP)</td><td valign="top">Endogenous KSRP was IP from N2a cells with SMN Tudor domain. KSRP and SMN colocalize in neuronal processes foci</td><td valign="top">mRNA stability, translation inhibition</td><td valign="top">Interacting with Drosha and Dicer complexes to regulate miRNA maturation and mRNA decay</td><td valign="top">KSRP is expressed in the nervous system in both neurons and glia and plays a role in control of neuronal mRNA stability and rate of axonal outgrowth</td><td valign="top">(<xref ref-type="bibr" rid="bib4">Amirouche et al., 2014</xref>; <xref ref-type="bibr" rid="bib119">Tadesse et al., 2008</xref>; <xref ref-type="bibr" rid="bib124">Trabucchi et al., 2009</xref>)</td></tr><tr><td valign="top">HuD (ELAV-like protein 4)</td><td valign="top">SMN and the neuron-specific RBP HuD interact biochemically in cultured primary cortical neurons, MN1-cells, cultured mouse MNs, rat brain extracts. Genetic evidence from zebrafish embryos support that the interaction between SMN and HuD is critical for MN development.</td><td valign="top">mRNA stability, transport, translation, mTOR pathway</td><td valign="top">Interacting with RISC<sup>d</sup> to regulate miRNA function</td><td valign="top">Axon development, maintenance, and plasticity</td><td valign="top">(<xref ref-type="bibr" rid="bib40">Fukao et al., 2014</xref>; <xref ref-type="bibr" rid="bib48">Hao le et al., 2017</xref>; <xref ref-type="bibr" rid="bib84">Loffreda et al., 2015</xref>; <xref ref-type="bibr" rid="bib114">Sosanya et al., 2013</xref>)</td></tr><tr><td valign="top">IMP1 (IGF2BP1; ZBP1), insulin-like growth factor 2 mRNA-binding protein 1</td><td valign="top">IP and GST pulldown SMN in brain lysates extracts using IMP1 antibody.</td><td valign="top">Promotes mRNA stability by preventing miRNA-mediated silencing</td><td valign="top">Interacting with AGO2 to regulate miRNA function</td><td valign="top">Axon development</td><td valign="top">(<xref ref-type="bibr" rid="bib37">Fallini et al., 2014</xref>; <xref ref-type="bibr" rid="bib42">Gardiner et al., 2015</xref>) <break/>(<xref ref-type="bibr" rid="bib25">Degrauwe et al., 2016</xref>)</td></tr></tbody></table><table-wrap-foot><fn><p>a. TDP-43 and FUS/TLS proteins bind to pre-mRNA molecules and determine their fates by regulating splicing, transport, stability and translation.</p><p>b. The RNA-binding protein, TDP43, biochemically interacts with the miRNA processing enzyme Drosha, raising the possibility that TDP-43 may play a role in miRNA processing.</p></fn><fn><p>c. FUS/TLS promotes biogenesis of specific miRNAs, including <italic>miR-132</italic>, <italic>miR-134</italic>, and <italic>miR-9</italic>.</p><p>d. Additional proteins associated with RISC include MOV10 and Hu-AntigenR.</p></fn></table-wrap-foot></table-wrap><p>A series of studies has shown dysregulation of specific miRNAs in SMA, and several of these studies have proposed potential links between aberrant miRNA expression and SMA pathophysiology in a diverse array of SMA animal models and patient samples, including neurons from nematodes, neurons and muscles from mice, as well as fibroblasts and serum from human patients (<xref ref-type="table" rid="table2">Table 2</xref>). Furthermore, transcriptome profiling has uncovered a number of miRNAs associated with MN survival, synapse formation, ER stress, and ribosomal RNA binding in models of SMA (<xref ref-type="bibr" rid="bib71">Kye and GonÃ§alves, 2014</xref>; <xref ref-type="bibr" rid="bib131">Vanderweyde et al., 2013</xref>; <xref ref-type="bibr" rid="bib133">Viswambharan et al., 2017</xref>). It remains under debate if dysregulated miRNAs and the corresponding miRNA-mediated target responses are cell-context dependent (i.e., specifically in MNs or in all neurons of the spinal cord), given that SMN is expressed ubiquitously and compromised expression of SMN may selectively affect miRNA homeostasis in different tissues (<xref ref-type="bibr" rid="bib88">Magri et al., 2018</xref>). In this regard, a very recent study aimed to identify miRNAs that are differentially regulated in SMA from iPSC-derived MNs (<xref ref-type="bibr" rid="bib62">Kaifer et al., 2019</xref>). In that study, Kaifer et al. only identified a subset of 16 miRNAs whose expression is significantly reduced more than 2-fold in SMA MNs when compared to control MNs. However, using a scAAV9 viral vector to reintroduce <italic>mir-23a</italic> into the Smn<sup>2B/-</sup> SMA mouse model increased MN size, reduced neuromuscular junction (NMJ) pathology, and extended survival. Although the detailed mechanisms underlying how <italic>miR-23a</italic>-mediated target pathways lead to SMA pathology have yet to be characterized, these findings suggest that only a cohort of miRNAs might cause the MN vulnerability in SMA and identification of those miRNA culprits and their targets could provide a new treatment strategy for SMA.</p><p>In addition to MNs, evidence for roles for miRNAs in muscle and glial cells that contribute to SMA is also emerging. By using both mouse and nematode models of SMA, O' Hern et al. showed that reduced SMN activity specifically affects <italic>miR-2</italic> expression, which in turn causes MNs to produce more m2R, a receptor for acetylcholine (<xref ref-type="bibr" rid="bib101">O'Hern et al., 2017</xref>). This result also indicates that reduced SMN levels might lead to NMJ dysfunction in MNs and suggests that dysregulation of neurotransmission could be another critical causative factor for SMA pathology. Interestingly, it was recently shown that SMN protein levels in astrocytes affect both directly and indirectly altered expression levels of <italic>miR-146a</italic> (<xref ref-type="bibr" rid="bib111">Sison et al., 2017</xref>). The proposed mechanism for that astrocyte-mediated SMA pathology was linked to increased levels of <italic>miR-146a</italic> in the SMNÎ7 mouse spinal cord. Although the precise targets of miR<italic>-146a</italic> have not yet been identified, treating iPSC-derived MNs with synthesized <italic>miR-146a</italic> molecules was sufficient to induce significant MN loss. This outcome indicates that SMA astrocyte-secreted <italic>miR-146a</italic> might lead to non-cell-autonomous loss of MNs. In the future, it is tantalizing to test gene therapy using miRNA cocktails from astrocytes and/or muscles cells, together with MN-intrinsic miRNAs to mitigate the SMA symptom.</p></sec><sec id="s4"><title>MicroRNAs as SMA biomarkers</title><p>Since SMA is a monogenetic disease, designing treatment strategies that restore SMN function in patients is a rational approach. Two undergoing SMA treatment trials either use antisense oligonucleotides or virus-mediated gene therapy exhibited promising outcomes (<xref ref-type="bibr" rid="bib39">Finkel et al., 2017</xref>; <xref ref-type="bibr" rid="bib91">Mendell et al., 2017</xref>). These therapeutic approaches both aim to increase SMN protein production in the spinal cord to restore motor function and survival. Mendell et al. used single intravenous administration of nonreplicating scAAV9 adenovirus vector carrying a human wild type SMN1 sequence. In contrast, Finkel et al. applied an antisense approach that was designed to enhance inclusion of exon seven in SMN2, which involved repetitive intrathecal administration of the antisense oligonucleotide drug Nusinersen. While there is cautious optimism regarding progress in developing SMA therapies, several new critical questions have arisen, particularly with regard to identifying measures of reliable outcomes in preclinical and clinical trials, given that: 1) intrathecal delivery is relatively invasive; 2) treatments remain prohibitively expensive; and 3) it remains unclear whether patientsâ responsive or non-responsive reactions to treatments reflects SMA heterogeneity. Accordingly, researchers have been prompted to identify more authentic biomarkers of SMA to facilitate patient classification, to follow disease progression, and to better monitor responses to therapeutic approaches using minimally invasive procedures. Reliable biomarkers would not only help categorize heterogeneous clinical types of SMA patients into homogeneous prognostic groups, but would also improve statistical power of clinical trials, reduce trial durations and costs, and reveal therapeutic effects in specific types of SMA patients (<xref ref-type="bibr" rid="bib24">De Paola et al., 2019</xref>; <xref ref-type="bibr" rid="bib133">Viswambharan et al., 2017</xref>).</p><p>Currently, the efficacy of SMA treatments is largely measured by clinical outcomes, including motor function, electrophysiological tests, and dependency on mechanical ventilation (<xref ref-type="bibr" rid="bib39">Finkel et al., 2017</xref>; <xref ref-type="bibr" rid="bib91">Mendell et al., 2017</xref>; <xref ref-type="bibr" rid="bib93">Mercuri et al., 2018</xref>). However, fluctuating inter-rater or intra-rater variabilities of motor function measurement is problematic and are usually confounded by diverse care regimens and age groups. It is conceivable that molecular biomarkers may represent more objective measures of treatment efficacy. Quantification of SMN mRNA or protein levels has served as the most commonly used molecular biomarker of SMA, but it does not necessarily correlate with disease severity and may not reliably reflect disease progression (<xref ref-type="bibr" rid="bib116">Sumner et al., 2006</xref>; <xref ref-type="bibr" rid="bib134">Wadman et al., 2016</xref>). MiRNAs have gained attention as an easily accessible biomarker due to their characteristic of being clinically detectable in many biofluids - such as cerebrospinal fluid, serum/plasma, saliva, and urine - using noninvasive methods (<xref ref-type="bibr" rid="bib133">Viswambharan et al., 2017</xref>). Indeed, miRNAs are now being used as novel clinical biomarkers for the prognosis of several diseases, including colorectal cancer, acute leukemia, coronary artery diseases, as well as neurodegenerative disorders (<xref ref-type="bibr" rid="bib143">Xu, 2012</xref>). Furthermore, miRNAs have also been proposed as potential biomarkers in several clinical trials for neuromuscular disorders (<xref ref-type="bibr" rid="bib2">Alexander and Kunkel, 2015</xref>; <xref ref-type="bibr" rid="bib123">Toivonen et al., 2014</xref>). Altered miRNA expression has been reported for spinal cord, brain, iPSCs, muscle, blood and cerebrospinal fluid of ALS patients (<xref ref-type="bibr" rid="bib50">Hawley et al., 2017</xref>; <xref ref-type="bibr" rid="bib128">Tung et al., 2019</xref>). As SMN is known to be involved in miRNA expression, circulating miRNAs may be used as diagnostic or prognostic biomarkers to reflect SMA pathology or therapeutic effects. As summarized in <xref ref-type="table" rid="table2">Table 2</xref>, <italic>miR-9</italic>, <italic>miR-132</italic>, <italic>miR-206</italic>, <italic>miR-183</italic> and <italic>miR-375</italic> have been proposed as potentially reliable SMA biomarkers (<xref ref-type="bibr" rid="bib57">Israeli et al., 2016</xref>; <xref ref-type="bibr" rid="bib105">Perry and Muntoni, 2016</xref>; <xref ref-type="bibr" rid="bib133">Viswambharan et al., 2017</xref>). However, it remains to be tested if any of these markers could serve as appropriate indicators of the efficacy of the aforementioned antisense oligonucleotide- or scAAV9-mediated treatments. Answering this question is imperative, as early identification of good patient responders by means of multiple sensitive outcome measures can decrease the cost of innovative therapeutics (<xref ref-type="bibr" rid="bib68">Kolb et al., 2016</xref>; <xref ref-type="bibr" rid="bib120">Taga and Maragakis, 2018</xref>). Notably, a recent phase 3 study of an antisense oligonucleotide treatment for severe infantile SMA revealed quite distinct responses among patients (<xref ref-type="bibr" rid="bib39">Finkel et al., 2017</xref>). In that study, the only factor identified as influencing treatment response was the time between recording the first symptoms in type I SMA patients and initial delivery of the antisense oligonucleotide. However, this factor would not seem to satisfactorily explain the wide variation in patient outcomes. Identification of a set of reliable miRNA markers from serum/cerebrospinal fluid that can be correlated with the Hammersmith Functional Motor Scale, a commonly used clinical parameter in SMA trials, might help stratify the variability among patients (<xref ref-type="bibr" rid="bib13">Catapano et al., 2016</xref>; <xref ref-type="bibr" rid="bib44">Gidaro and Servais, 2019</xref>).</p></sec><sec id="s5"><title>Conclusion and future perspective</title><p>The relevance of miRNAs to development and disease contexts has been gaining increasing attention over the past two decades. Many miRNA knockout mouse lines have been shown to manifest significant neural development phenotypes (<xref ref-type="bibr" rid="bib7">Bartel, 2018</xref>), and miRNAs were shown to be sufficient to facilitate reprogramming of fibroblasts into neurons, including into spinal MNs (<xref ref-type="bibr" rid="bib1">Abernathy et al., 2017</xref>). In this review, we summarize the reported functions of miRNAs in the development and degeneration of spinal MNs. AlthoughÂ ~5 miRNAs are highly or specifically expressed in MNs, only two mouse knockout lines (i.e., <italic>miR-17Â ~92<sup>MNÎ</sup></italic> and a <italic>miR-218</italic> double knockout) have been characterized in detail. Thus, it would be prudent to further verify the proposed roles of <italic>miR-196</italic> and <italic>miR-9</italic> in the regulation of Hoxb8 and Foxp1 by examining their respective knockout mouse lines (<xref ref-type="bibr" rid="bib110">Shibata et al., 2011</xref>; <xref ref-type="bibr" rid="bib139">Wong et al., 2015</xref>). It is relatively tedious to generate miRNA knockout mice as many miRNAs have evolved duplicated paralogs in mammals (<xref ref-type="bibr" rid="bib103">Park et al., 2012</xref>), hindering functional studies of miRNAs in mouse models. Fortunately, this hurdle can now be circumvented by CRISPR-Cas9 technology. Accordingly, we envision that further mechanistic insights into the miRNA-TF network of cell fate specification and maintenance during spinal MN development will be revealed by mouse genetic approaches in the near future.</p><p>Despite miRNAs reportedly serving as potential biomarkers for cancer prognosis and progression (<xref ref-type="bibr" rid="bib51">Hayes et al., 2014</xref>), their potential applications in neurodegenerative disease remain to be fully validated. In the case of SMA discussed here, emerging evidence indicates that SMN deficiency can impact non-neuronal organ systems, which may be reflected by altered levels of specific miRNAs in serum (<xref ref-type="bibr" rid="bib47">Hamilton and Gillingwater, 2013</xref>; <xref ref-type="bibr" rid="bib56">Hua et al., 2015</xref>). However, critical challenges remain, such as unraveling inconsistencies due to human subject variability and technical issues related to the relative fragility of miRNAs (<xref ref-type="bibr" rid="bib8">Basak et al., 2016</xref>; <xref ref-type="bibr" rid="bib133">Viswambharan et al., 2017</xref>). Although SMA-iPSCs might overcome some of these difficulties, it will be critical to recruit a large cohort of patients to validate the authenticity of miRNA biomarkers and further promote their utility.</p><p>Finally, twenty years after the breakthrough discovery illustrating how RNA interference can be used to silence certain genes, the U.S. Food and Drug Administration has approved the first drug utilizing this method for adult clinical treatment of a rare disease (i.e., hereditary transthyretin-mediated amyloidosis). However, as for antisense oligonucleotide treatment in SMA, the cost is prohibitive. Other significant challenges that must be overcome before routine utilization of miRNA-based therapy in neurodegenerative diseases include establishing the best route of delivery and ensuring miRNA therapeutics can cross the blood-brain barrier. In addition, given that miRNAs often act through multiple pathways, the risk of off-target effects must be addressed, especially since they are frequently cited as a side-effect of molecular therapies. Lastly, the timing of miRNA regulation according to cellular developmental status must also be taken into consideration, with miRNA levels being manipulated at a precise time-point with an optimal dosage.</p><p>In conclusion, miRNAs are just as critical as TFs for MN development, and miRNA dysregulation likely plays an important role in SMA pathogenesis and in determining the selective vulnerability of MNs. Considering the rapid pace of our expanding knowledge on non-coding RNAs and the introduction of cutting-edge single-cell RNA/ATAC sequencing technology (<xref ref-type="bibr" rid="bib26">Delile et al., 2019</xref>), research into the role of miRNAs in neural development and degeneration has just begun.</p></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We appreciate Kuan-Chih Peng and Ya-Yin Tsai for their help to prepare the figures, and the members in the JAC Lab to proofread the manuscript. Work in the Jun-An Chen lab is supported by grants from the NHRI (NHRI-EX108-10831NI), Academia Sinica (CDA-107-L05), and MOST (108â2311-B-001â011). Funding in the Tai-Heng Chen lab is via MOST (106â2314-B-037â086) and research grants from Kaohsiung Medical University (KMUH104-4M52 and KMUH105-5M49).</p></ack><sec id="s6" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abernathy</surname> <given-names>DG</given-names></name><name><surname>Kim</surname> <given-names>WK</given-names></name><name><surname>McCoy</surname> <given-names>MJ</given-names></name><name><surname>Lake</surname> <given-names>AM</given-names></name><name><surname>Ouwenga</surname> <given-names>R</given-names></name><name><surname>Lee</surname> <given-names>SW</given-names></name><name><surname>Xing</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>D</given-names></name><name><surname>Lee</surname> <given-names>HJ</given-names></name><name><surname>Heuckeroth</surname> <given-names>RO</given-names></name><name><surname>Dougherty</surname> <given-names>JD</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Yoo</surname> <given-names>AS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>MicroRNAs induce a permissive chromatin environment that enables neuronal Subtype-Specific reprogramming of adult human fibroblasts</article-title><source>Cell Stem Cell</source><volume>21</volume><fpage>332</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2017.08.002</pub-id><pub-id pub-id-type="pmid">28886366</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname> <given-names>MS</given-names></name><name><surname>Kunkel</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Skeletal muscle MicroRNAs: their diagnostic and therapeutic potential in human muscle diseases</article-title><source>Journal of Neuromuscular Diseases</source><volume>2</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.3233/JND-140058</pub-id><pub-id pub-id-type="pmid">27547731</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amin</surname> <given-names>ND</given-names></name><name><surname>Bai</surname> <given-names>G</given-names></name><name><surname>Klug</surname> <given-names>JR</given-names></name><name><surname>Bonanomi</surname> <given-names>D</given-names></name><name><surname>Pankratz</surname> <given-names>MT</given-names></name><name><surname>Gifford</surname> <given-names>WD</given-names></name><name><surname>Hinckley</surname> <given-names>CA</given-names></name><name><surname>Sternfeld</surname> <given-names>MJ</given-names></name><name><surname>Driscoll</surname> <given-names>SP</given-names></name><name><surname>Dominguez</surname> <given-names>B</given-names></name><name><surname>Lee</surname> <given-names>KF</given-names></name><name><surname>Jin</surname> <given-names>X</given-names></name><name><surname>Pfaff</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Loss of motoneuron-specific microRNA-218 causes systemic neuromuscular failure</article-title><source>Science</source><volume>350</volume><fpage>1525</fpage><lpage>1529</lpage><pub-id pub-id-type="doi">10.1126/science.aad2509</pub-id><pub-id pub-id-type="pmid">26680198</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amirouche</surname> <given-names>A</given-names></name><name><surname>Tadesse</surname> <given-names>H</given-names></name><name><surname>Miura</surname> <given-names>P</given-names></name><name><surname>BÃ©langer</surname> <given-names>G</given-names></name><name><surname>Lunde</surname> <given-names>JA</given-names></name><name><surname>CÃ´tÃ©</surname> <given-names>J</given-names></name><name><surname>Jasmin</surname> <given-names>BJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Converging pathways involving microRNA-206 and the RNA-binding protein KSRP control post-transcriptionally utrophin A expression in skeletal muscle</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>3982</fpage><lpage>3997</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt1350</pub-id><pub-id pub-id-type="pmid">24371285</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asli</surname> <given-names>NS</given-names></name><name><surname>Kessel</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Spatiotemporally restricted regulation of generic motor neuron programs by miR-196-mediated repression of Hoxb8</article-title><source>Developmental Biology</source><volume>344</volume><fpage>857</fpage><lpage>868</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2010.06.003</pub-id><pub-id pub-id-type="pmid">20553899</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balaskas</surname> <given-names>N</given-names></name><name><surname>Ribeiro</surname> <given-names>A</given-names></name><name><surname>Panovska</surname> <given-names>J</given-names></name><name><surname>Dessaud</surname> <given-names>E</given-names></name><name><surname>Sasai</surname> <given-names>N</given-names></name><name><surname>Page</surname> <given-names>KM</given-names></name><name><surname>Briscoe</surname> <given-names>J</given-names></name><name><surname>Ribes</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Gene regulatory logic for reading the sonic hedgehog signaling gradient in the vertebrate neural tube</article-title><source>Cell</source><volume>148</volume><fpage>273</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.10.047</pub-id><pub-id pub-id-type="pmid">22265416</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartel</surname> <given-names>DP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Metazoan MicroRNAs</article-title><source>Cell</source><volume>173</volume><fpage>20</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.03.006</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basak</surname> <given-names>I</given-names></name><name><surname>Patil</surname> <given-names>KS</given-names></name><name><surname>Alves</surname> <given-names>G</given-names></name><name><surname>Larsen</surname> <given-names>JP</given-names></name><name><surname>MÃ¸ller</surname> <given-names>SG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases</article-title><source>Cellular and Molecular Life Sciences</source><volume>73</volume><fpage>811</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.1007/s00018-015-2093-x</pub-id><pub-id pub-id-type="pmid">26608596</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertrandy</surname> <given-names>S</given-names></name><name><surname>Burlet</surname> <given-names>P</given-names></name><name><surname>Clermont</surname> <given-names>O</given-names></name><name><surname>Huber</surname> <given-names>C</given-names></name><name><surname>Fondrat</surname> <given-names>C</given-names></name><name><surname>Thierry-Mieg</surname> <given-names>D</given-names></name><name><surname>Munnich</surname> <given-names>A</given-names></name><name><surname>Lefebvre</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The RNA-binding properties of SMN: deletion analysis of the zebrafish orthologue defines domains conserved in evolution</article-title><source>Human Molecular Genetics</source><volume>8</volume><fpage>775</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1093/hmg/8.5.775</pub-id><pub-id pub-id-type="pmid">10196366</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhinge</surname> <given-names>A</given-names></name><name><surname>Namboori</surname> <given-names>SC</given-names></name><name><surname>Bithell</surname> <given-names>A</given-names></name><name><surname>Soldati</surname> <given-names>C</given-names></name><name><surname>Buckley</surname> <given-names>NJ</given-names></name><name><surname>Stanton</surname> <given-names>LW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>MiR-375 is Essential for Human Spinal Motor Neuron Development and May Be Involved in Motor Neuron Degeneration</article-title><source>Stem Cells</source><volume>34</volume><fpage>124</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1002/stem.2233</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Briscoe</surname> <given-names>J</given-names></name><name><surname>Pierani</surname> <given-names>A</given-names></name><name><surname>Jessell</surname> <given-names>TM</given-names></name><name><surname>Ericson</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>A homeodomain protein code specifies progenitor cell identity and neuronal fate in the ventral neural tube</article-title><source>Cell</source><volume>101</volume><fpage>435</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80853-3</pub-id><pub-id pub-id-type="pmid">10830170</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burghes</surname> <given-names>AH</given-names></name><name><surname>Beattie</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?</article-title><source>Nature Reviews Neuroscience</source><volume>10</volume><fpage>597</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1038/nrn2670</pub-id><pub-id pub-id-type="pmid">19584893</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catapano</surname> <given-names>F</given-names></name><name><surname>Zaharieva</surname> <given-names>I</given-names></name><name><surname>Scoto</surname> <given-names>M</given-names></name><name><surname>Marrosu</surname> <given-names>E</given-names></name><name><surname>Morgan</surname> <given-names>J</given-names></name><name><surname>Muntoni</surname> <given-names>F</given-names></name><name><surname>Zhou</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Altered levels of MicroRNA-9, -206, and -132 in spinal muscular atrophy and their response to antisense oligonucleotide therapy</article-title><source>Molecular Therapy - Nucleic Acids</source><volume>5</volume><elocation-id>e331</elocation-id><pub-id pub-id-type="doi">10.1038/mtna.2016.47</pub-id><pub-id pub-id-type="pmid">27377135</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catela</surname> <given-names>C</given-names></name><name><surname>Shin</surname> <given-names>MM</given-names></name><name><surname>Dasen</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Assembly and function of spinal circuits for motor control</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>31</volume><fpage>669</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100814-125155</pub-id><pub-id pub-id-type="pmid">26393773</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cauchi</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>SMN and gemins: 'we are family' â¦ or are we?: insights into the partnership between Gemins and the spinal muscular atrophy disease protein SMN</article-title><source>BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology</source><volume>32</volume><fpage>1077</fpage><lpage>1089</lpage><pub-id pub-id-type="doi">10.1002/bies.201000088</pub-id><pub-id pub-id-type="pmid">20954180</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>JA</given-names></name><name><surname>Chu</surname> <given-names>ST</given-names></name><name><surname>Amaya</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Maintenance of motor neuron progenitors in <italic>Xenopus</italic> requires a novel localized cyclin</article-title><source>EMBO Reports</source><volume>8</volume><fpage>287</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1038/sj.embor.7400903</pub-id><pub-id pub-id-type="pmid">17304238</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>JA</given-names></name><name><surname>Huang</surname> <given-names>YP</given-names></name><name><surname>Mazzoni</surname> <given-names>EO</given-names></name><name><surname>Tan</surname> <given-names>GC</given-names></name><name><surname>Zavadil</surname> <given-names>J</given-names></name><name><surname>Wichterle</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mir-17-3p controls spinal neural progenitor patterning by regulating Olig2/Irx3 cross-repressive loop</article-title><source>Neuron</source><volume>69</volume><fpage>721</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.01.014</pub-id><pub-id pub-id-type="pmid">21338882</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>JA</given-names></name><name><surname>Wichterle</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Apoptosis of limb innervating motor neurons and erosion of motor pool identity upon lineage specific dicer inactivation</article-title><source>Frontiers in Neuroscience</source><volume>6</volume><elocation-id>69</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2012.00069</pub-id><pub-id pub-id-type="pmid">22629237</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crawford</surname> <given-names>TO</given-names></name><name><surname>Paushkin</surname> <given-names>SV</given-names></name><name><surname>Kobayashi</surname> <given-names>DT</given-names></name><name><surname>Forrest</surname> <given-names>SJ</given-names></name><name><surname>Joyce</surname> <given-names>CL</given-names></name><name><surname>Finkel</surname> <given-names>RS</given-names></name><name><surname>Kaufmann</surname> <given-names>P</given-names></name><name><surname>Swoboda</surname> <given-names>KJ</given-names></name><name><surname>Tiziano</surname> <given-names>D</given-names></name><name><surname>Lomastro</surname> <given-names>R</given-names></name><name><surname>Li</surname> <given-names>RH</given-names></name><name><surname>Trachtenberg</surname> <given-names>FL</given-names></name><name><surname>Plasterer</surname> <given-names>T</given-names></name><name><surname>Chen</surname> <given-names>KS</given-names></name><collab>Pilot Study of Biomarkers for Spinal Muscular Atrophy Trial Group</collab></person-group><year iso-8601-date="2012">2012</year><article-title>Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e33572</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0033572</pub-id><pub-id pub-id-type="pmid">22558076</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dasen</surname> <given-names>JS</given-names></name><name><surname>Liu</surname> <given-names>J-P</given-names></name><name><surname>Jessell</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Motor neuron columnar fate imposed by sequential phases of Hox-c activity</article-title><source>Nature</source><volume>425</volume><fpage>926</fpage><lpage>933</lpage><pub-id pub-id-type="doi">10.1038/nature02051</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dasen</surname> <given-names>JS</given-names></name><name><surname>Tice</surname> <given-names>BC</given-names></name><name><surname>Brenner-Morton</surname> <given-names>S</given-names></name><name><surname>Jessell</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A hox regulatory network establishes motor neuron pool identity and target-muscle connectivity</article-title><source>Cell</source><volume>123</volume><fpage>477</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.09.009</pub-id><pub-id pub-id-type="pmid">16269338</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dasen</surname> <given-names>JS</given-names></name><name><surname>De Camilli</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>B</given-names></name><name><surname>Tucker</surname> <given-names>PW</given-names></name><name><surname>Jessell</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Hox repertoires for motor neuron diversity and connectivity gated by a single accessory factor, FoxP1</article-title><source>Cell</source><volume>134</volume><fpage>304</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2008.06.019</pub-id><pub-id pub-id-type="pmid">18662545</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Marco Garcia</surname> <given-names>NV</given-names></name><name><surname>Jessell</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Early motor neuron pool identity and muscle nerve trajectory defined by postmitotic restrictions in Nkx6.1 activity</article-title><source>Neuron</source><volume>57</volume><fpage>217</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2007.11.033</pub-id><pub-id pub-id-type="pmid">18215620</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Paola</surname> <given-names>E</given-names></name><name><surname>Verdile</surname> <given-names>V</given-names></name><name><surname>Paronetto</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dysregulation of microRNA metabolism in motor neuron diseases: novel biomarkers and potential therapeutics</article-title><source>Non-Coding RNA Research</source><volume>4</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.ncrna.2018.12.001</pub-id><pub-id pub-id-type="pmid">30891533</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Degrauwe</surname> <given-names>N</given-names></name><name><surname>SuvÃ </surname> <given-names>ML</given-names></name><name><surname>Janiszewska</surname> <given-names>M</given-names></name><name><surname>Riggi</surname> <given-names>N</given-names></name><name><surname>Stamenkovic</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and Cancer</article-title><source>Genes &amp; Development</source><volume>30</volume><fpage>2459</fpage><lpage>2474</lpage><pub-id pub-id-type="doi">10.1101/gad.287540.116</pub-id><pub-id pub-id-type="pmid">27940961</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delile</surname> <given-names>J</given-names></name><name><surname>Rayon</surname> <given-names>T</given-names></name><name><surname>Melchionda</surname> <given-names>M</given-names></name><name><surname>Edwards</surname> <given-names>A</given-names></name><name><surname>Briscoe</surname> <given-names>J</given-names></name><name><surname>Sagner</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single cell transcriptomics reveals spatial and temporal dynamics of gene expression in the developing mouse spinal cord</article-title><source>Development</source><volume>146</volume><elocation-id>dev173807</elocation-id><pub-id pub-id-type="doi">10.1242/dev.173807</pub-id><pub-id pub-id-type="pmid">30846445</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dessaud</surname> <given-names>E</given-names></name><name><surname>Yang</surname> <given-names>LL</given-names></name><name><surname>Hill</surname> <given-names>K</given-names></name><name><surname>Cox</surname> <given-names>B</given-names></name><name><surname>Ulloa</surname> <given-names>F</given-names></name><name><surname>Ribeiro</surname> <given-names>A</given-names></name><name><surname>Mynett</surname> <given-names>A</given-names></name><name><surname>Novitch</surname> <given-names>BG</given-names></name><name><surname>Briscoe</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Interpretation of the sonic hedgehog morphogen gradient by a temporal adaptation mechanism</article-title><source>Nature</source><volume>450</volume><fpage>717</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1038/nature06347</pub-id><pub-id pub-id-type="pmid">18046410</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dessaud</surname> <given-names>E</given-names></name><name><surname>Ribes</surname> <given-names>V</given-names></name><name><surname>Balaskas</surname> <given-names>N</given-names></name><name><surname>Yang</surname> <given-names>LL</given-names></name><name><surname>Pierani</surname> <given-names>A</given-names></name><name><surname>Kicheva</surname> <given-names>A</given-names></name><name><surname>Novitch</surname> <given-names>BG</given-names></name><name><surname>Briscoe</surname> <given-names>J</given-names></name><name><surname>Sasai</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Dynamic assignment and maintenance of positional identity in the ventral neural tube by the morphogen sonic hedgehog</article-title><source>PLOS Biology</source><volume>8</volume><elocation-id>e1000382</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1000382</pub-id><pub-id pub-id-type="pmid">20532235</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donlin-Asp</surname> <given-names>PG</given-names></name><name><surname>Bassell</surname> <given-names>GJ</given-names></name><name><surname>Rossoll</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A role for the survival of motor neuron protein in mRNP assembly and transport</article-title><source>Current Opinion in Neurobiology</source><volume>39</volume><fpage>53</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2016.04.004</pub-id><pub-id pub-id-type="pmid">27131421</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dostie</surname> <given-names>J</given-names></name><name><surname>Mourelatos</surname> <given-names>Z</given-names></name><name><surname>Yang</surname> <given-names>M</given-names></name><name><surname>Sharma</surname> <given-names>A</given-names></name><name><surname>Dreyfuss</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Numerous microRNPs in neuronal cells containing novel microRNAs</article-title><source>RNA</source><volume>9</volume><fpage>180</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1261/rna.2141503</pub-id><pub-id pub-id-type="pmid">12554860</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DâElia</surname> <given-names>KP</given-names></name><name><surname>Dasen</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Development, functional organization, and evolution of vertebrate axial motor circuits</article-title><source>Neural Development</source><volume>13</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.1186/s13064-018-0108-7</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edbauer</surname> <given-names>D</given-names></name><name><surname>Neilson</surname> <given-names>JR</given-names></name><name><surname>Foster</surname> <given-names>KA</given-names></name><name><surname>Wang</surname> <given-names>CF</given-names></name><name><surname>Seeburg</surname> <given-names>DP</given-names></name><name><surname>Batterton</surname> <given-names>MN</given-names></name><name><surname>Tada</surname> <given-names>T</given-names></name><name><surname>Dolan</surname> <given-names>BM</given-names></name><name><surname>Sharp</surname> <given-names>PA</given-names></name><name><surname>Sheng</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132</article-title><source>Neuron</source><volume>65</volume><fpage>373</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.01.005</pub-id><pub-id pub-id-type="pmid">20159450</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eitan</surname> <given-names>C</given-names></name><name><surname>Hornstein</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Vulnerability of microRNA biogenesis in FTD-ALS</article-title><source>Brain Research</source><volume>1647</volume><fpage>105</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2015.12.063</pub-id><pub-id pub-id-type="pmid">26778173</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emde</surname> <given-names>A</given-names></name><name><surname>Eitan</surname> <given-names>C</given-names></name><name><surname>Liou</surname> <given-names>LL</given-names></name><name><surname>Libby</surname> <given-names>RT</given-names></name><name><surname>Rivkin</surname> <given-names>N</given-names></name><name><surname>Magen</surname> <given-names>I</given-names></name><name><surname>Reichenstein</surname> <given-names>I</given-names></name><name><surname>Oppenheim</surname> <given-names>H</given-names></name><name><surname>Eilam</surname> <given-names>R</given-names></name><name><surname>Silvestroni</surname> <given-names>A</given-names></name><name><surname>Alajajian</surname> <given-names>B</given-names></name><name><surname>Ben-Dov</surname> <given-names>IZ</given-names></name><name><surname>Aebischer</surname> <given-names>J</given-names></name><name><surname>Savidor</surname> <given-names>A</given-names></name><name><surname>Levin</surname> <given-names>Y</given-names></name><name><surname>Sons</surname> <given-names>R</given-names></name><name><surname>Hammond</surname> <given-names>SM</given-names></name><name><surname>Ravits</surname> <given-names>JM</given-names></name><name><surname>MÃ¶ller</surname> <given-names>T</given-names></name><name><surname>Hornstein</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS</article-title><source>The EMBO Journal</source><volume>34</volume><fpage>2633</fpage><lpage>2651</lpage><pub-id pub-id-type="doi">10.15252/embj.201490493</pub-id><pub-id pub-id-type="pmid">26330466</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erb</surname> <given-names>M</given-names></name><name><surname>Lee</surname> <given-names>B</given-names></name><name><surname>Yeon Seo</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>JW</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The Isl1-Lhx3 complex promotes motor neuron specification by activating transcriptional pathways that enhance its own expression and formation</article-title><source>Eneuro</source><volume>4</volume><elocation-id>ENEURO.0349-16.2017</elocation-id><pub-id pub-id-type="doi">10.1523/ENEURO.0349-16.2017</pub-id><pub-id pub-id-type="pmid">28451636</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fallini</surname> <given-names>C</given-names></name><name><surname>Bassell</surname> <given-names>GJ</given-names></name><name><surname>Rossoll</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Spinal muscular atrophy: the role of SMN in axonal mRNA regulation</article-title><source>Brain Research</source><volume>1462</volume><fpage>81</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2012.01.044</pub-id><pub-id pub-id-type="pmid">22330725</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fallini</surname> <given-names>C</given-names></name><name><surname>Rouanet</surname> <given-names>JP</given-names></name><name><surname>Donlin-Asp</surname> <given-names>PG</given-names></name><name><surname>Guo</surname> <given-names>P</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Singer</surname> <given-names>RH</given-names></name><name><surname>Rossoll</surname> <given-names>W</given-names></name><name><surname>Bassell</surname> <given-names>GJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Dynamics of survival of motor neuron (SMN) protein interaction with the mRNA-binding protein IMP1 facilitates its trafficking into motor neuron axons</article-title><source>Developmental Neurobiology</source><volume>74</volume><fpage>319</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1002/dneu.22111</pub-id><pub-id pub-id-type="pmid">23897586</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fetcho</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>A review of the organization and evolution of motoneurons innervating the axial musculature of vertebrates</article-title><source>Brain Research Reviews</source><volume>12</volume><fpage>243</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1016/0165-0173(87)90001-4</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finkel</surname> <given-names>RS</given-names></name><name><surname>Mercuri</surname> <given-names>E</given-names></name><name><surname>Darras</surname> <given-names>BT</given-names></name><name><surname>Connolly</surname> <given-names>AM</given-names></name><name><surname>Kuntz</surname> <given-names>NL</given-names></name><name><surname>Kirschner</surname> <given-names>J</given-names></name><name><surname>Chiriboga</surname> <given-names>CA</given-names></name><name><surname>Saito</surname> <given-names>K</given-names></name><name><surname>Servais</surname> <given-names>L</given-names></name><name><surname>Tizzano</surname> <given-names>E</given-names></name><name><surname>Topaloglu</surname> <given-names>H</given-names></name><name><surname>Tulinius</surname> <given-names>M</given-names></name><name><surname>Montes</surname> <given-names>J</given-names></name><name><surname>Glanzman</surname> <given-names>AM</given-names></name><name><surname>Bishop</surname> <given-names>K</given-names></name><name><surname>Zhong</surname> <given-names>ZJ</given-names></name><name><surname>Gheuens</surname> <given-names>S</given-names></name><name><surname>Bennett</surname> <given-names>CF</given-names></name><name><surname>Schneider</surname> <given-names>E</given-names></name><name><surname>Farwell</surname> <given-names>W</given-names></name><name><surname>De Vivo</surname> <given-names>DC</given-names></name><collab>ENDEAR Study Group</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Nusinersen versus sham control in Infantile-Onset spinal muscular atrophy</article-title><source>New England Journal of Medicine</source><volume>377</volume><fpage>1723</fpage><lpage>1732</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1702752</pub-id><pub-id pub-id-type="pmid">29091570</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukao</surname> <given-names>A</given-names></name><name><surname>Mishima</surname> <given-names>Y</given-names></name><name><surname>Takizawa</surname> <given-names>N</given-names></name><name><surname>Oka</surname> <given-names>S</given-names></name><name><surname>Imataka</surname> <given-names>H</given-names></name><name><surname>Pelletier</surname> <given-names>J</given-names></name><name><surname>Sonenberg</surname> <given-names>N</given-names></name><name><surname>Thoma</surname> <given-names>C</given-names></name><name><surname>Fujiwara</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>MicroRNAs trigger dissociation of eIF4AI and eIF4AII from target mRNAs in humans</article-title><source>Molecular Cell</source><volume>56</volume><fpage>79</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2014.09.005</pub-id><pub-id pub-id-type="pmid">25280105</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabanella</surname> <given-names>F</given-names></name><name><surname>Butchbach</surname> <given-names>ME</given-names></name><name><surname>Saieva</surname> <given-names>L</given-names></name><name><surname>Carissimi</surname> <given-names>C</given-names></name><name><surname>Burghes</surname> <given-names>AH</given-names></name><name><surname>Pellizzoni</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs</article-title><source>PLOS ONE</source><volume>2</volume><elocation-id>e921</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0000921</pub-id><pub-id pub-id-type="pmid">17895963</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardiner</surname> <given-names>AS</given-names></name><name><surname>Twiss</surname> <given-names>JL</given-names></name><name><surname>Perrone-Bizzozero</surname> <given-names>NI</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Competing interactions of RNA-Binding proteins, MicroRNAs, and their targets control neuronal development and function</article-title><source>Biomolecules</source><volume>5</volume><fpage>2903</fpage><lpage>2918</lpage><pub-id pub-id-type="doi">10.3390/biom5042903</pub-id><pub-id pub-id-type="pmid">26512708</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname> <given-names>A</given-names></name><name><surname>Kolodkin</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Specification of neuronal connectivity: ets marks the spot</article-title><source>Cell</source><volume>95</volume><fpage>303</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81762-6</pub-id><pub-id pub-id-type="pmid">9814701</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gidaro</surname> <given-names>T</given-names></name><name><surname>Servais</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Nusinersen treatment of spinal muscular atrophy: current knowledge and existing gaps</article-title><source>Developmental Medicine &amp; Child Neurology</source><volume>61</volume><fpage>19</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1111/dmcn.14027</pub-id><pub-id pub-id-type="pmid">30221755</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>GonÃ§alves</surname> <given-names>I</given-names></name><name><surname>Brecht</surname> <given-names>J</given-names></name><name><surname>Thelen</surname> <given-names>MP</given-names></name><name><surname>Rehorst</surname> <given-names>WA</given-names></name><name><surname>Peters</surname> <given-names>M</given-names></name><name><surname>Lee</surname> <given-names>HJ</given-names></name><name><surname>Motameny</surname> <given-names>S</given-names></name><name><surname>Torres-Benito</surname> <given-names>L</given-names></name><name><surname>Ebrahimi-Fakhari</surname> <given-names>D</given-names></name><name><surname>Kononenko</surname> <given-names>NL</given-names></name><name><surname>AltmÃ¼ller</surname> <given-names>J</given-names></name><name><surname>Vilchez</surname> <given-names>D</given-names></name><name><surname>Sahin</surname> <given-names>M</given-names></name><name><surname>Wirth</surname> <given-names>B</given-names></name><name><surname>Kye</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>7907</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-26347-y</pub-id><pub-id pub-id-type="pmid">29784949</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haase</surname> <given-names>G</given-names></name><name><surname>Dessaud</surname> <given-names>E</given-names></name><name><surname>GarcÃ¨s</surname> <given-names>A</given-names></name><name><surname>de Bovis</surname> <given-names>B</given-names></name><name><surname>Birling</surname> <given-names>M</given-names></name><name><surname>Filippi</surname> <given-names>P</given-names></name><name><surname>Schmalbruch</surname> <given-names>H</given-names></name><name><surname>Arber</surname> <given-names>S</given-names></name><name><surname>deLapeyriÃ¨re</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>GDNF acts through PEA3 to regulate cell body positioning and muscle innervation of specific motor neuron pools</article-title><source>Neuron</source><volume>35</volume><fpage>893</fpage><lpage>905</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(02)00864-4</pub-id><pub-id pub-id-type="pmid">12372284</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname> <given-names>G</given-names></name><name><surname>Gillingwater</surname> <given-names>TH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Spinal muscular atrophy: going beyond the motor neuron</article-title><source>Trends in Molecular Medicine</source><volume>19</volume><fpage>40</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2012.11.002</pub-id><pub-id pub-id-type="pmid">23228902</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao le</surname> <given-names>T</given-names></name><name><surname>Duy</surname> <given-names>PQ</given-names></name><name><surname>An</surname> <given-names>M</given-names></name><name><surname>Talbot</surname> <given-names>J</given-names></name><name><surname>Iyer</surname> <given-names>CC</given-names></name><name><surname>Wolman</surname> <given-names>M</given-names></name><name><surname>Beattie</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>HuD and the survival motor neuron protein interact in Motoneurons and are essential for motoneuron development, function, and mRNA regulation</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>11559</fpage><lpage>11571</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1528-17.2017</pub-id><pub-id pub-id-type="pmid">29061699</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haramati</surname> <given-names>S</given-names></name><name><surname>Chapnik</surname> <given-names>E</given-names></name><name><surname>Sztainberg</surname> <given-names>Y</given-names></name><name><surname>Eilam</surname> <given-names>R</given-names></name><name><surname>Zwang</surname> <given-names>R</given-names></name><name><surname>Gershoni</surname> <given-names>N</given-names></name><name><surname>McGlinn</surname> <given-names>E</given-names></name><name><surname>Heiser</surname> <given-names>PW</given-names></name><name><surname>Wills</surname> <given-names>AM</given-names></name><name><surname>Wirguin</surname> <given-names>I</given-names></name><name><surname>Rubin</surname> <given-names>LL</given-names></name><name><surname>Misawa</surname> <given-names>H</given-names></name><name><surname>Tabin</surname> <given-names>CJ</given-names></name><name><surname>Brown</surname> <given-names>R</given-names></name><name><surname>Chen</surname> <given-names>A</given-names></name><name><surname>Hornstein</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>miRNA malfunction causes spinal motor neuron disease</article-title><source>PNAS</source><volume>107</volume><fpage>13111</fpage><lpage>13116</lpage><pub-id pub-id-type="doi">10.1073/pnas.1006151107</pub-id><pub-id pub-id-type="pmid">20616011</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawley</surname> <given-names>ZCE</given-names></name><name><surname>Campos-Melo</surname> <given-names>D</given-names></name><name><surname>Droppelmann</surname> <given-names>CA</given-names></name><name><surname>Strong</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>MotomiRs: mirnas in motor neuron function and disease</article-title><source>Frontiers in Molecular Neuroscience</source><volume>10</volume><elocation-id>127</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2017.00127</pub-id><pub-id pub-id-type="pmid">28522960</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname> <given-names>J</given-names></name><name><surname>Peruzzi</surname> <given-names>PP</given-names></name><name><surname>Lawler</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>MicroRNAs in Cancer: biomarkers, functions and therapy</article-title><source>Trends in Molecular Medicine</source><volume>20</volume><fpage>460</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2014.06.005</pub-id><pub-id pub-id-type="pmid">25027972</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hobert</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Regulatory logic of neuronal diversity: terminal selector genes and selector motifs</article-title><source>PNAS</source><volume>105</volume><fpage>20067</fpage><lpage>20071</lpage><pub-id pub-id-type="doi">10.1073/pnas.0806070105</pub-id><pub-id pub-id-type="pmid">19104055</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollyday</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1980">1980a</year><article-title>Motoneuron histogenesis and the development of limb innervation</article-title><source>Current Topics in Developmental Biology</source><volume>15 Pt 1</volume><fpage>181</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/s0070-2153(08)60120-9</pub-id><pub-id pub-id-type="pmid">7449425</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollyday</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1980">1980b</year><article-title>Organization of motor pools in the chick lumbar lateral motor column</article-title><source>The Journal of Comparative Neurology</source><volume>194</volume><fpage>143</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1002/cne.901940108</pub-id><pub-id pub-id-type="pmid">7192292</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoye</surname> <given-names>ML</given-names></name><name><surname>Koval</surname> <given-names>ED</given-names></name><name><surname>Wegener</surname> <given-names>AJ</given-names></name><name><surname>Hyman</surname> <given-names>TS</given-names></name><name><surname>Yang</surname> <given-names>C</given-names></name><name><surname>O'Brien</surname> <given-names>DR</given-names></name><name><surname>Miller</surname> <given-names>RL</given-names></name><name><surname>Cole</surname> <given-names>T</given-names></name><name><surname>Schoch</surname> <given-names>KM</given-names></name><name><surname>Shen</surname> <given-names>T</given-names></name><name><surname>Kunikata</surname> <given-names>T</given-names></name><name><surname>Richard</surname> <given-names>JP</given-names></name><name><surname>Gutmann</surname> <given-names>DH</given-names></name><name><surname>Maragakis</surname> <given-names>NJ</given-names></name><name><surname>Kordasiewicz</surname> <given-names>HB</given-names></name><name><surname>Dougherty</surname> <given-names>JD</given-names></name><name><surname>Miller</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>MicroRNA profiling reveals marker of motor neuron disease in ALS models</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>5574</fpage><lpage>5586</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3582-16.2017</pub-id><pub-id pub-id-type="pmid">28416596</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>YH</given-names></name><name><surname>Sahashi</surname> <given-names>K</given-names></name><name><surname>Rigo</surname> <given-names>F</given-names></name><name><surname>Bennett</surname> <given-names>CF</given-names></name><name><surname>Krainer</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models</article-title><source>Genes &amp; Development</source><volume>29</volume><fpage>288</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1101/gad.256644.114</pub-id><pub-id pub-id-type="pmid">25583329</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Israeli</surname> <given-names>D</given-names></name><name><surname>Poupiot</surname> <given-names>J</given-names></name><name><surname>Amor</surname> <given-names>F</given-names></name><name><surname>Charton</surname> <given-names>K</given-names></name><name><surname>Lostal</surname> <given-names>W</given-names></name><name><surname>Jeanson-Leh</surname> <given-names>L</given-names></name><name><surname>Richard</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>28097</elocation-id><pub-id pub-id-type="doi">10.1038/srep28097</pub-id><pub-id pub-id-type="pmid">27323895</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>P</given-names></name><name><surname>Zarnescu</surname> <given-names>DC</given-names></name><name><surname>Ceman</surname> <given-names>S</given-names></name><name><surname>Nakamoto</surname> <given-names>M</given-names></name><name><surname>Mowrey</surname> <given-names>J</given-names></name><name><surname>Jongens</surname> <given-names>TA</given-names></name><name><surname>Nelson</surname> <given-names>DL</given-names></name><name><surname>Moses</surname> <given-names>K</given-names></name><name><surname>Warren</surname> <given-names>ST</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway</article-title><source>Nature Neuroscience</source><volume>7</volume><fpage>113</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1038/nn1174</pub-id><pub-id pub-id-type="pmid">14703574</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jodelka</surname> <given-names>FM</given-names></name><name><surname>Ebert</surname> <given-names>AD</given-names></name><name><surname>Duelli</surname> <given-names>DM</given-names></name><name><surname>Hastings</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A feedback loop regulates splicing of the spinal muscular atrophy-modifying gene, SMN2</article-title><source>Human Molecular Genetics</source><volume>19</volume><fpage>4906</fpage><lpage>4917</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddq425</pub-id><pub-id pub-id-type="pmid">20884664</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jukam</surname> <given-names>D</given-names></name><name><surname>Desplan</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Binary fate decisions in differentiating neurons</article-title><source>Current Opinion in Neurobiology</source><volume>20</volume><fpage>6</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2009.11.002</pub-id><pub-id pub-id-type="pmid">20022236</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname> <given-names>H</given-names></name><name><surname>Lacombe</surname> <given-names>J</given-names></name><name><surname>Mazzoni</surname> <given-names>EO</given-names></name><name><surname>Liem</surname> <given-names>KF</given-names></name><name><surname>Grinstein</surname> <given-names>J</given-names></name><name><surname>Mahony</surname> <given-names>S</given-names></name><name><surname>Mukhopadhyay</surname> <given-names>D</given-names></name><name><surname>Gifford</surname> <given-names>DK</given-names></name><name><surname>Young</surname> <given-names>RA</given-names></name><name><surname>Anderson</surname> <given-names>KV</given-names></name><name><surname>Wichterle</surname> <given-names>H</given-names></name><name><surname>Dasen</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Global control of motor neuron topography mediated by the repressive actions of a single hox gene</article-title><source>Neuron</source><volume>67</volume><fpage>781</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.08.008</pub-id><pub-id pub-id-type="pmid">20826310</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaifer</surname> <given-names>KA</given-names></name><name><surname>VillalÃ³n</surname> <given-names>E</given-names></name><name><surname>O'Brien</surname> <given-names>BS</given-names></name><name><surname>Sison</surname> <given-names>SL</given-names></name><name><surname>Smith</surname> <given-names>CE</given-names></name><name><surname>Simon</surname> <given-names>ME</given-names></name><name><surname>Marquez</surname> <given-names>J</given-names></name><name><surname>O'Day</surname> <given-names>S</given-names></name><name><surname>Hopkins</surname> <given-names>AE</given-names></name><name><surname>Neff</surname> <given-names>R</given-names></name><name><surname>Rindt</surname> <given-names>H</given-names></name><name><surname>Ebert</surname> <given-names>AD</given-names></name><name><surname>Lorson</surname> <given-names>CL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>AAV9-mediated delivery of miR-23a reduces disease severity in Smn2B/âSMA model mice</article-title><source>Human Molecular Genetics</source><volume>80</volume><pub-id pub-id-type="doi">10.1093/hmg/ddz142</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kania</surname> <given-names>A</given-names></name><name><surname>Jessell</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Topographic motor projections in the limb imposed by LIM homeodomain protein regulation of ephrin-A:epha interactions</article-title><source>Neuron</source><volume>38</volume><fpage>581</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(03)00292-7</pub-id><pub-id pub-id-type="pmid">12765610</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanning</surname> <given-names>KC</given-names></name><name><surname>Kaplan</surname> <given-names>A</given-names></name><name><surname>Henderson</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Motor neuron diversity in development and disease</article-title><source>Annual Review of Neuroscience</source><volume>33</volume><fpage>409</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.051508.135722</pub-id><pub-id pub-id-type="pmid">20367447</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawahara</surname> <given-names>Y</given-names></name><name><surname>Mieda-Sato</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>TDP-43 promotes microRNA biogenesis as a component of the drosha and dicer complexes</article-title><source>PNAS</source><volume>109</volume><fpage>3347</fpage><lpage>3352</lpage><pub-id pub-id-type="doi">10.1073/pnas.1112427109</pub-id><pub-id pub-id-type="pmid">22323604</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kicheva</surname> <given-names>A</given-names></name><name><surname>Bollenbach</surname> <given-names>T</given-names></name><name><surname>Ribeiro</surname> <given-names>A</given-names></name><name><surname>Valle</surname> <given-names>HP</given-names></name><name><surname>Lovell-Badge</surname> <given-names>R</given-names></name><name><surname>Episkopou</surname> <given-names>V</given-names></name><name><surname>Briscoe</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Coordination of progenitor specification and growth in mouse and chick spinal cord</article-title><source>Science</source><volume>345</volume><elocation-id>1254927</elocation-id><pub-id pub-id-type="doi">10.1126/science.1254927</pub-id><pub-id pub-id-type="pmid">25258086</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>M</given-names></name><name><surname>Bjorke</surname> <given-names>B</given-names></name><name><surname>Mastick</surname> <given-names>GS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Motor neuron migration and positioning mechanisms: new roles for guidance cues</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>85</volume><fpage>78</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2017.11.016</pub-id><pub-id pub-id-type="pmid">29141180</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolb</surname> <given-names>SJ</given-names></name><name><surname>Coffey</surname> <given-names>CS</given-names></name><name><surname>Yankey</surname> <given-names>JW</given-names></name><name><surname>Krosschell</surname> <given-names>K</given-names></name><name><surname>Arnold</surname> <given-names>WD</given-names></name><name><surname>Rutkove</surname> <given-names>SB</given-names></name><name><surname>Swoboda</surname> <given-names>KJ</given-names></name><name><surname>Reyna</surname> <given-names>SP</given-names></name><name><surname>Sakonju</surname> <given-names>A</given-names></name><name><surname>Darras</surname> <given-names>BT</given-names></name><name><surname>Shell</surname> <given-names>R</given-names></name><name><surname>Kuntz</surname> <given-names>N</given-names></name><name><surname>Castro</surname> <given-names>D</given-names></name><name><surname>Iannaccone</surname> <given-names>ST</given-names></name><name><surname>Parsons</surname> <given-names>J</given-names></name><name><surname>Connolly</surname> <given-names>AM</given-names></name><name><surname>Chiriboga</surname> <given-names>CA</given-names></name><name><surname>McDonald</surname> <given-names>C</given-names></name><name><surname>Burnette</surname> <given-names>WB</given-names></name><name><surname>Werner</surname> <given-names>K</given-names></name><name><surname>Thangarajh</surname> <given-names>M</given-names></name><name><surname>Shieh</surname> <given-names>PB</given-names></name><name><surname>Finanger</surname> <given-names>E</given-names></name><name><surname>Cudkowicz</surname> <given-names>ME</given-names></name><name><surname>McGovern</surname> <given-names>MM</given-names></name><name><surname>McNeil</surname> <given-names>DE</given-names></name><name><surname>Finkel</surname> <given-names>R</given-names></name><name><surname>Kaye</surname> <given-names>E</given-names></name><name><surname>Kingsley</surname> <given-names>A</given-names></name><name><surname>Renusch</surname> <given-names>SR</given-names></name><name><surname>McGovern</surname> <given-names>VL</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Zaworski</surname> <given-names>PG</given-names></name><name><surname>Prior</surname> <given-names>TW</given-names></name><name><surname>Burghes</surname> <given-names>AH</given-names></name><name><surname>Bartlett</surname> <given-names>A</given-names></name><name><surname>Kissel</surname> <given-names>JT</given-names></name><collab>NeuroNEXT Clinical Trial Network and on behalf of the NN101 SMA Biomarker Investigators</collab></person-group><year iso-8601-date="2016">2016</year><article-title>Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study</article-title><source>Annals of Clinical and Translational Neurology</source><volume>3</volume><fpage>132</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1002/acn3.283</pub-id><pub-id pub-id-type="pmid">26900585</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kutejova</surname> <given-names>E</given-names></name><name><surname>Sasai</surname> <given-names>N</given-names></name><name><surname>Shah</surname> <given-names>A</given-names></name><name><surname>Gouti</surname> <given-names>M</given-names></name><name><surname>Briscoe</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Neural progenitors adopt specific identities by directly repressing all alternative progenitor transcriptional programs</article-title><source>Developmental Cell</source><volume>36</volume><fpage>639</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2016.02.013</pub-id><pub-id pub-id-type="pmid">26972603</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kye</surname> <given-names>MJ</given-names></name><name><surname>Niederst</surname> <given-names>ED</given-names></name><name><surname>Wertz</surname> <given-names>MH</given-names></name><name><surname>GonÃ§alves</surname> <given-names>IC</given-names></name><name><surname>Akten</surname> <given-names>B</given-names></name><name><surname>Dover</surname> <given-names>KZ</given-names></name><name><surname>Peters</surname> <given-names>M</given-names></name><name><surname>Riessland</surname> <given-names>M</given-names></name><name><surname>Neveu</surname> <given-names>P</given-names></name><name><surname>Wirth</surname> <given-names>B</given-names></name><name><surname>Kosik</surname> <given-names>KS</given-names></name><name><surname>Sardi</surname> <given-names>SP</given-names></name><name><surname>Monani</surname> <given-names>UR</given-names></name><name><surname>Passini</surname> <given-names>MA</given-names></name><name><surname>Sahin</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>SMN regulates axonal local translation via miR-183/mTOR pathway</article-title><source>Human Molecular Genetics</source><volume>23</volume><fpage>6318</fpage><lpage>6331</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddu350</pub-id><pub-id pub-id-type="pmid">25055867</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kye</surname> <given-names>MJ</given-names></name><name><surname>GonÃ§alves</surname> <given-names>IC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The role of miRNA in motor neuron disease</article-title><source>Frontiers in Cellular Neuroscience</source><volume>8</volume><elocation-id>15</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2014.00015</pub-id><pub-id pub-id-type="pmid">24523674</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacombe</surname> <given-names>J</given-names></name><name><surname>Hanley</surname> <given-names>O</given-names></name><name><surname>Jung</surname> <given-names>H</given-names></name><name><surname>Philippidou</surname> <given-names>P</given-names></name><name><surname>Surmeli</surname> <given-names>G</given-names></name><name><surname>Grinstein</surname> <given-names>J</given-names></name><name><surname>Dasen</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genetic and functional modularity of hox activities in the specification of limb-innervating motor neurons</article-title><source>PLOS Genetics</source><volume>9</volume><elocation-id>e1003184</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1003184</pub-id><pub-id pub-id-type="pmid">23359544</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lance-Jones</surname> <given-names>C</given-names></name><name><surname>Landmesser</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="1980">1980</year><article-title>Motoneurone projection patterns in the chick hind limb following early partial reversals of the spinal cord</article-title><source>The Journal of Physiology</source><volume>302</volume><fpage>581</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1980.sp013262</pub-id><pub-id pub-id-type="pmid">7411470</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lance-Jones</surname> <given-names>C</given-names></name><name><surname>Landmesser</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>Pathway selection by chick lumbosacral motoneurons during normal development</article-title><source>Proceedings of the Royal Society of London. Series B, Biological Sciences</source><volume>214</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1098/rspb.1981.0079</pub-id><pub-id pub-id-type="pmid">6121327</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landmesser</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="1978">1978a</year><article-title>The development of motor projection patterns in the chick hind limb</article-title><source>The Journal of Physiology</source><volume>284</volume><fpage>391</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1978.sp012546</pub-id><pub-id pub-id-type="pmid">731552</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landmesser</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="1978">1978b</year><article-title>The distribution of motoneurones supplying chick hind limb muscles</article-title><source>The Journal of Physiology</source><volume>284</volume><fpage>371</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1978.sp012545</pub-id><pub-id pub-id-type="pmid">731549</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Cuvillier</surname> <given-names>JM</given-names></name><name><surname>Lee</surname> <given-names>B</given-names></name><name><surname>Shen</surname> <given-names>R</given-names></name><name><surname>Lee</surname> <given-names>JW</given-names></name><name><surname>Lee</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fusion protein Isl1-Lhx3 specifies motor neuron fate by inducing motor neuron genes and concomitantly suppressing the interneuron programs</article-title><source>PNAS</source><volume>109</volume><fpage>3383</fpage><lpage>3388</lpage><pub-id pub-id-type="doi">10.1073/pnas.1114515109</pub-id><pub-id pub-id-type="pmid">22343290</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname> <given-names>BP</given-names></name><name><surname>Burge</surname> <given-names>CB</given-names></name><name><surname>Bartel</surname> <given-names>DP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets</article-title><source>Cell</source><volume>120</volume><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2004.12.035</pub-id><pub-id pub-id-type="pmid">15652477</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>CJ</given-names></name><name><surname>Hong</surname> <given-names>T</given-names></name><name><surname>Tung</surname> <given-names>YT</given-names></name><name><surname>Yen</surname> <given-names>YP</given-names></name><name><surname>Hsu</surname> <given-names>HC</given-names></name><name><surname>Lu</surname> <given-names>YL</given-names></name><name><surname>Chang</surname> <given-names>M</given-names></name><name><surname>Nie</surname> <given-names>Q</given-names></name><name><surname>Chen</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>MicroRNA filters hox temporal transcription noise to confer boundary formation in the spinal cord</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14685</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14685</pub-id><pub-id pub-id-type="pmid">28337978</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lien</surname> <given-names>HW</given-names></name><name><surname>Yuan</surname> <given-names>RY</given-names></name><name><surname>Chou</surname> <given-names>CM</given-names></name><name><surname>Chen</surname> <given-names>YC</given-names></name><name><surname>Hung</surname> <given-names>CC</given-names></name><name><surname>Hu</surname> <given-names>CH</given-names></name><name><surname>Hwang</surname> <given-names>SP</given-names></name><name><surname>Hwang</surname> <given-names>PP</given-names></name><name><surname>Shen</surname> <given-names>CN</given-names></name><name><surname>Chen</surname> <given-names>CL</given-names></name><name><surname>Cheng</surname> <given-names>CH</given-names></name><name><surname>Huang</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Zebrafish cyclin dx is required for development of motor neuron progenitors, and its expression is regulated by hypoxia-inducible factor 2Î±</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>28297</elocation-id><pub-id pub-id-type="doi">10.1038/srep28297</pub-id><pub-id pub-id-type="pmid">27323909</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>CM</given-names></name><name><surname>Wang</surname> <given-names>RY</given-names></name><name><surname>Saijilafu</surname></name> <name><surname>Jiao</surname> <given-names>ZX</given-names></name><name><surname>Zhang</surname> <given-names>BY</given-names></name><name><surname>Zhou</surname> <given-names>FQ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>MicroRNA-138 and SIRT1 form a mutual negative feedback loop to regulate mammalian axon regeneration</article-title><source>Genes &amp; Development</source><volume>27</volume><fpage>1473</fpage><lpage>1483</lpage><pub-id pub-id-type="doi">10.1101/gad.209619.112</pub-id><pub-id pub-id-type="pmid">23796896</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livet</surname> <given-names>J</given-names></name><name><surname>Sigrist</surname> <given-names>M</given-names></name><name><surname>Stroebel</surname> <given-names>S</given-names></name><name><surname>De Paola</surname> <given-names>V</given-names></name><name><surname>Price</surname> <given-names>SR</given-names></name><name><surname>Henderson</surname> <given-names>CE</given-names></name><name><surname>Jessell</surname> <given-names>TM</given-names></name><name><surname>Arber</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>ETS gene Pea3 controls the central position and terminal arborization of specific motor neuron pools</article-title><source>Neuron</source><volume>35</volume><fpage>877</fpage><lpage>892</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(02)00863-2</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobjois</surname> <given-names>V</given-names></name><name><surname>Bel-Vialar</surname> <given-names>S</given-names></name><name><surname>Trousse</surname> <given-names>F</given-names></name><name><surname>Pituello</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Forcing neural progenitor cells to cycle is insufficient to alter cell-fate decision and timing of neuronal differentiation in the spinal cord</article-title><source>Neural Development</source><volume>3</volume><elocation-id>4</elocation-id><pub-id pub-id-type="doi">10.1186/1749-8104-3-4</pub-id><pub-id pub-id-type="pmid">18271960</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loffreda</surname> <given-names>A</given-names></name><name><surname>Rigamonti</surname> <given-names>A</given-names></name><name><surname>Barabino</surname> <given-names>SM</given-names></name><name><surname>Lenzken</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>RNA-Binding proteins in the regulation of miRNA activity: a focus on neuronal functions</article-title><source>Biomolecules</source><volume>5</volume><fpage>2363</fpage><lpage>2387</lpage><pub-id pub-id-type="doi">10.3390/biom5042363</pub-id><pub-id pub-id-type="pmid">26437437</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luchetti</surname> <given-names>A</given-names></name><name><surname>CiafrÃ¨</surname> <given-names>SA</given-names></name><name><surname>Murdocca</surname> <given-names>M</given-names></name><name><surname>Malgieri</surname> <given-names>A</given-names></name><name><surname>Masotti</surname> <given-names>A</given-names></name><name><surname>Sanchez</surname> <given-names>M</given-names></name><name><surname>Farace</surname> <given-names>MG</given-names></name><name><surname>Novelli</surname> <given-names>G</given-names></name><name><surname>Sangiuolo</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A perturbed MicroRNA expression pattern characterizes embryonic neural stem cells derived from a severe mouse model of spinal muscular atrophy (SMA)</article-title><source>International Journal of Molecular Sciences</source><volume>16</volume><fpage>18312</fpage><lpage>18327</lpage><pub-id pub-id-type="doi">10.3390/ijms160818312</pub-id><pub-id pub-id-type="pmid">26258776</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lunn</surname> <given-names>MR</given-names></name><name><surname>Wang</surname> <given-names>CH</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Spinal muscular atrophy</article-title><source>The Lancet</source><volume>371</volume><fpage>2120</fpage><lpage>2133</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(08)60921-6</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luxenhofer</surname> <given-names>G</given-names></name><name><surname>Helmbrecht</surname> <given-names>MS</given-names></name><name><surname>Langhoff</surname> <given-names>J</given-names></name><name><surname>Giusti</surname> <given-names>SA</given-names></name><name><surname>Refojo</surname> <given-names>D</given-names></name><name><surname>Huber</surname> <given-names>AB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>MicroRNA-9 promotes the switch from early-born to late-born motor neuron populations by regulating onecut transcription factor expression</article-title><source>Developmental Biology</source><volume>386</volume><fpage>358</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2013.12.023</pub-id><pub-id pub-id-type="pmid">24374159</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magri</surname> <given-names>F</given-names></name><name><surname>Vanoli</surname> <given-names>F</given-names></name><name><surname>Corti</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>miRNA in spinal muscular atrophy pathogenesis and therapy</article-title><source>Journal of Cellular and Molecular Medicine</source><volume>22</volume><fpage>755</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1111/jcmm.13450</pub-id><pub-id pub-id-type="pmid">29160009</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McHanwell</surname> <given-names>S</given-names></name><name><surname>Biscoe</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>The localization of motoneurons supplying the hindlimb muscles of the mouse</article-title><source>Philosophical Transactions of the Royal Society B: Biological Sciences</source><volume>293</volume><fpage>477</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1098/rstb.1981.0082</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meister</surname> <given-names>G</given-names></name><name><surname>Fischer</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Assisted RNP assembly: smn and PRMT5 complexes cooperate in the formation of spliceosomal UsnRNPs</article-title><source>The EMBO Journal</source><volume>21</volume><fpage>5853</fpage><lpage>5863</lpage><pub-id pub-id-type="doi">10.1093/emboj/cdf585</pub-id><pub-id pub-id-type="pmid">12411503</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendell</surname> <given-names>JR</given-names></name><name><surname>Al-Zaidy</surname> <given-names>S</given-names></name><name><surname>Shell</surname> <given-names>R</given-names></name><name><surname>Arnold</surname> <given-names>WD</given-names></name><name><surname>Rodino-Klapac</surname> <given-names>LR</given-names></name><name><surname>Prior</surname> <given-names>TW</given-names></name><name><surname>Lowes</surname> <given-names>L</given-names></name><name><surname>Alfano</surname> <given-names>L</given-names></name><name><surname>Berry</surname> <given-names>K</given-names></name><name><surname>Church</surname> <given-names>K</given-names></name><name><surname>Kissel</surname> <given-names>JT</given-names></name><name><surname>Nagendran</surname> <given-names>S</given-names></name><name><surname>L'Italien</surname> <given-names>J</given-names></name><name><surname>Sproule</surname> <given-names>DM</given-names></name><name><surname>Wells</surname> <given-names>C</given-names></name><name><surname>Cardenas</surname> <given-names>JA</given-names></name><name><surname>Heitzer</surname> <given-names>MD</given-names></name><name><surname>Kaspar</surname> <given-names>A</given-names></name><name><surname>Corcoran</surname> <given-names>S</given-names></name><name><surname>Braun</surname> <given-names>L</given-names></name><name><surname>Likhite</surname> <given-names>S</given-names></name><name><surname>Miranda</surname> <given-names>C</given-names></name><name><surname>Meyer</surname> <given-names>K</given-names></name><name><surname>Foust</surname> <given-names>KD</given-names></name><name><surname>Burghes</surname> <given-names>AHM</given-names></name><name><surname>Kaspar</surname> <given-names>BK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-Dose Gene-Replacement therapy for spinal muscular atrophy</article-title><source>New England Journal of Medicine</source><volume>377</volume><fpage>1713</fpage><lpage>1722</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1706198</pub-id><pub-id pub-id-type="pmid">29091557</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendelsohn</surname> <given-names>AI</given-names></name><name><surname>Dasen</surname> <given-names>JS</given-names></name><name><surname>Jessell</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Divergent hox coding and evasion of retinoid signaling specifies motor neurons innervating digit muscles</article-title><source>Neuron</source><volume>93</volume><fpage>792</fpage><lpage>805</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.01.017</pub-id><pub-id pub-id-type="pmid">28190640</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercuri</surname> <given-names>E</given-names></name><name><surname>Darras</surname> <given-names>BT</given-names></name><name><surname>Chiriboga</surname> <given-names>CA</given-names></name><name><surname>Day</surname> <given-names>JW</given-names></name><name><surname>Campbell</surname> <given-names>C</given-names></name><name><surname>Connolly</surname> <given-names>AM</given-names></name><name><surname>Iannaccone</surname> <given-names>ST</given-names></name><name><surname>Kirschner</surname> <given-names>J</given-names></name><name><surname>Kuntz</surname> <given-names>NL</given-names></name><name><surname>Saito</surname> <given-names>K</given-names></name><name><surname>Shieh</surname> <given-names>PB</given-names></name><name><surname>Tulinius</surname> <given-names>M</given-names></name><name><surname>Mazzone</surname> <given-names>ES</given-names></name><name><surname>Montes</surname> <given-names>J</given-names></name><name><surname>Bishop</surname> <given-names>KM</given-names></name><name><surname>Yang</surname> <given-names>Q</given-names></name><name><surname>Foster</surname> <given-names>R</given-names></name><name><surname>Gheuens</surname> <given-names>S</given-names></name><name><surname>Bennett</surname> <given-names>CF</given-names></name><name><surname>Farwell</surname> <given-names>W</given-names></name><name><surname>Schneider</surname> <given-names>E</given-names></name><name><surname>De Vivo</surname> <given-names>DC</given-names></name><name><surname>Finkel</surname> <given-names>RS</given-names></name><collab>CHERISH Study Group</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Nusinersen versus sham control in Later-Onset spinal muscular atrophy</article-title><source>New England Journal of Medicine</source><volume>378</volume><fpage>625</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1710504</pub-id><pub-id pub-id-type="pmid">29443664</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyazaki</surname> <given-names>Y</given-names></name><name><surname>Adachi</surname> <given-names>H</given-names></name><name><surname>Katsuno</surname> <given-names>M</given-names></name><name><surname>Minamiyama</surname> <given-names>M</given-names></name><name><surname>Jiang</surname> <given-names>YM</given-names></name><name><surname>Huang</surname> <given-names>Z</given-names></name><name><surname>Doi</surname> <given-names>H</given-names></name><name><surname>Matsumoto</surname> <given-names>S</given-names></name><name><surname>Kondo</surname> <given-names>N</given-names></name><name><surname>Iida</surname> <given-names>M</given-names></name><name><surname>Tohnai</surname> <given-names>G</given-names></name><name><surname>Tanaka</surname> <given-names>F</given-names></name><name><surname>Muramatsu</surname> <given-names>S</given-names></name><name><surname>Sobue</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2</article-title><source>Nature Medicine</source><volume>18</volume><fpage>1136</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1038/nm.2791</pub-id><pub-id pub-id-type="pmid">22660636</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morlando</surname> <given-names>M</given-names></name><name><surname>Dini Modigliani</surname> <given-names>S</given-names></name><name><surname>Torrelli</surname> <given-names>G</given-names></name><name><surname>Rosa</surname> <given-names>A</given-names></name><name><surname>Di Carlo</surname> <given-names>V</given-names></name><name><surname>Caffarelli</surname> <given-names>E</given-names></name><name><surname>Bozzoni</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>FUS stimulates microRNA biogenesis by facilitating co-transcriptional drosha recruitment</article-title><source>The EMBO Journal</source><volume>31</volume><fpage>4502</fpage><lpage>4510</lpage><pub-id pub-id-type="doi">10.1038/emboj.2012.319</pub-id><pub-id pub-id-type="pmid">23232809</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mourelatos</surname> <given-names>Z</given-names></name><name><surname>Dostie</surname> <given-names>J</given-names></name><name><surname>Paushkin</surname> <given-names>S</given-names></name><name><surname>Sharma</surname> <given-names>A</given-names></name><name><surname>Charroux</surname> <given-names>B</given-names></name><name><surname>Abel</surname> <given-names>L</given-names></name><name><surname>Rappsilber</surname> <given-names>J</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name><name><surname>Dreyfuss</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs</article-title><source>Genes &amp; Development</source><volume>16</volume><fpage>720</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1101/gad.974702</pub-id><pub-id pub-id-type="pmid">11914277</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murdocca</surname> <given-names>M</given-names></name><name><surname>CiafrÃ¨</surname> <given-names>S</given-names></name><name><surname>Spitalieri</surname> <given-names>P</given-names></name><name><surname>Talarico</surname> <given-names>R</given-names></name><name><surname>Sanchez</surname> <given-names>M</given-names></name><name><surname>Novelli</surname> <given-names>G</given-names></name><name><surname>Sangiuolo</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>SMA human iPSC-Derived motor neurons show perturbed differentiation and reduced miR-335-5p expression</article-title><source>International Journal of Molecular Sciences</source><volume>17</volume><elocation-id>1231</elocation-id><pub-id pub-id-type="doi">10.3390/ijms17081231</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>LM</given-names></name><name><surname>Beauvais</surname> <given-names>A</given-names></name><name><surname>Gibeault</surname> <given-names>S</given-names></name><name><surname>Courtney</surname> <given-names>NL</given-names></name><name><surname>Kothary</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the smn (2b/-) mouse model of spinal muscular atrophy</article-title><source>Acta Neuropathologica Communications</source><volume>3</volume><fpage>55</fpage><pub-id pub-id-type="doi">10.1186/s40478-015-0231-1</pub-id><pub-id pub-id-type="pmid">26374403</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname> <given-names>PT</given-names></name><name><surname>Hatzigeorgiou</surname> <given-names>AG</given-names></name><name><surname>Mourelatos</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>miRNP:mRNA association in polyribosomes in a human neuronal cell line</article-title><source>RNA</source><volume>10</volume><fpage>387</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1261/rna.5181104</pub-id><pub-id pub-id-type="pmid">14970384</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novitch</surname> <given-names>BG</given-names></name><name><surname>Chen</surname> <given-names>AI</given-names></name><name><surname>Jessell</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Coordinate regulation of motor neuron subtype identity and pan-neuronal properties by the bHLH repressor Olig2</article-title><source>Neuron</source><volume>31</volume><fpage>773</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(01)00407-X</pub-id><pub-id pub-id-type="pmid">11567616</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Hern</surname> <given-names>PJ</given-names></name><name> <surname>GonÃ§alves</surname> <given-names>I</given-names></name><name><surname>do Carmo</surname> <given-names>G</given-names></name><name><surname>Brecht</surname> <given-names>J</given-names></name><name><surname>LÃ³pez Soto</surname> <given-names>EJ</given-names></name><name><surname>Simon</surname> <given-names>J</given-names></name><name><surname>Chapkis</surname> <given-names>N</given-names></name><name><surname>Lipscombe</surname> <given-names>D</given-names></name><name><surname>Kye</surname> <given-names>MJ</given-names></name><name><surname>Hart</surname> <given-names>AC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Decreased microRNA levels lead to deleterious increases in neuronal M2 muscarinic receptors in spinal muscular atrophy models</article-title><source>eLife</source><volume>6</volume><elocation-id>e20752</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.20752</pub-id><pub-id pub-id-type="pmid">28463115</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otaegi</surname> <given-names>G</given-names></name><name><surname>Pollock</surname> <given-names>A</given-names></name><name><surname>Hong</surname> <given-names>J</given-names></name><name><surname>Sun</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>MicroRNA miR-9 modifies motor neuron columns by a tuning regulation of FoxP1 levels in developing spinal cords</article-title><source>Journal of Neuroscience</source><volume>31</volume><fpage>809</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4330-10.2011</pub-id><pub-id pub-id-type="pmid">21248104</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>CY</given-names></name><name><surname>Jeker</surname> <given-names>LT</given-names></name><name><surname>Carver-Moore</surname> <given-names>K</given-names></name><name><surname>Oh</surname> <given-names>A</given-names></name><name><surname>Liu</surname> <given-names>HJ</given-names></name><name><surname>Cameron</surname> <given-names>R</given-names></name><name><surname>Richards</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Adler</surname> <given-names>D</given-names></name><name><surname>Yoshinaga</surname> <given-names>Y</given-names></name><name><surname>Martinez</surname> <given-names>M</given-names></name><name><surname>Nefadov</surname> <given-names>M</given-names></name><name><surname>Abbas</surname> <given-names>AK</given-names></name><name><surname>Weiss</surname> <given-names>A</given-names></name><name><surname>Lanier</surname> <given-names>LL</given-names></name><name><surname>de Jong</surname> <given-names>PJ</given-names></name><name><surname>Bluestone</surname> <given-names>JA</given-names></name><name><surname>Srivastava</surname> <given-names>D</given-names></name><name><surname>McManus</surname> <given-names>MT</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A resource for the conditional ablation of microRNAs in the mouse</article-title><source>Cell Reports</source><volume>1</volume><fpage>385</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2012.02.008</pub-id><pub-id pub-id-type="pmid">22570807</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellizzoni</surname> <given-names>L</given-names></name><name><surname>Baccon</surname> <given-names>J</given-names></name><name><surname>Rappsilber</surname> <given-names>J</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name><name><surname>Dreyfuss</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Purification of native survival of motor neurons complexes and identification of Gemin6 as a novel component</article-title><source>Journal of Biological Chemistry</source><volume>277</volume><fpage>7540</fpage><lpage>7545</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110141200</pub-id><pub-id pub-id-type="pmid">11748230</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname> <given-names>MM</given-names></name><name><surname>Muntoni</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Noncoding RNAs and duchenne muscular dystrophy</article-title><source>Epigenomics</source><volume>8</volume><fpage>1527</fpage><lpage>1537</lpage><pub-id pub-id-type="doi">10.2217/epi-2016-0088</pub-id><pub-id pub-id-type="pmid">27603567</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piazzon</surname> <given-names>N</given-names></name><name><surname>Rage</surname> <given-names>F</given-names></name><name><surname>Schlotter</surname> <given-names>F</given-names></name><name><surname>Moine</surname> <given-names>H</given-names></name><name><surname>Branlant</surname> <given-names>C</given-names></name><name><surname>Massenet</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>In vitro and in cellulo evidences for association of the survival of motor neuron complex with the fragile X mental retardation protein</article-title><source>Journal of Biological Chemistry</source><volume>283</volume><fpage>5598</fpage><lpage>5610</lpage><pub-id pub-id-type="doi">10.1074/jbc.M707304200</pub-id><pub-id pub-id-type="pmid">18093976</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajman</surname> <given-names>M</given-names></name><name><surname>Schratt</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>MicroRNAs in neural development: from master regulators to fine-tuners</article-title><source>Development</source><volume>144</volume><fpage>2310</fpage><lpage>2322</lpage><pub-id pub-id-type="doi">10.1242/dev.144337</pub-id><pub-id pub-id-type="pmid">28676566</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravanidis</surname> <given-names>S</given-names></name><name><surname>Kattan</surname> <given-names>F-G</given-names></name><name><surname>Doxakis</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Unraveling the pathways to neuronal homeostasis and disease: mechanistic insights into the role of RNA-Binding proteins and associated factors</article-title><source>International Journal of Molecular Sciences</source><volume>19</volume><elocation-id>2280</elocation-id><pub-id pub-id-type="doi">10.3390/ijms19082280</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romanes</surname> <given-names>GJ</given-names></name></person-group><year iso-8601-date="1964">1964</year><article-title>The motor pools of the spinal cord</article-title><source>Progress in Brain Research</source><volume>11</volume><fpage>93</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/s0079-6123(08)64045-5</pub-id><pub-id pub-id-type="pmid">14300484</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibata</surname> <given-names>M</given-names></name><name><surname>Nakao</surname> <given-names>H</given-names></name><name><surname>Kiyonari</surname> <given-names>H</given-names></name><name><surname>Abe</surname> <given-names>T</given-names></name><name><surname>Aizawa</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>MicroRNA-9 regulates neurogenesis in mouse telencephalon by targeting multiple transcription factors</article-title><source>Journal of Neuroscience</source><volume>31</volume><fpage>3407</fpage><lpage>3422</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5085-10.2011</pub-id><pub-id pub-id-type="pmid">21368052</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sison</surname> <given-names>SL</given-names></name><name><surname>Patitucci</surname> <given-names>TN</given-names></name><name><surname>Seminary</surname> <given-names>ER</given-names></name><name><surname>Villalon</surname> <given-names>E</given-names></name><name><surname>Lorson</surname> <given-names>CL</given-names></name><name><surname>Ebert</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy</article-title><source>Human Molecular Genetics</source><volume>26</volume><fpage>3409</fpage><lpage>3420</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx230</pub-id><pub-id pub-id-type="pmid">28637335</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Small</surname> <given-names>EM</given-names></name><name><surname>Sutherland</surname> <given-names>LB</given-names></name><name><surname>Rajagopalan</surname> <given-names>KN</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Olson</surname> <given-names>EN</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>MicroRNA-218 regulates vascular patterning by modulation of Slit-Robo signaling</article-title><source>Circulation Research</source><volume>107</volume><fpage>1336</fpage><lpage>1344</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.227926</pub-id><pub-id pub-id-type="pmid">20947829</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sockanathan</surname> <given-names>S</given-names></name><name><surname>Jessell</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Motor neuron-derived retinoid signaling specifies the subtype identity of spinal motor neurons</article-title><source>Cell</source><volume>94</volume><fpage>503</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81591-3</pub-id><pub-id pub-id-type="pmid">9727493</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sosanya</surname> <given-names>NM</given-names></name><name><surname>Huang</surname> <given-names>PP</given-names></name><name><surname>Cacheaux</surname> <given-names>LP</given-names></name><name><surname>Chen</surname> <given-names>CJ</given-names></name><name><surname>Nguyen</surname> <given-names>K</given-names></name><name><surname>Perrone-Bizzozero</surname> <given-names>NI</given-names></name><name><surname>Raab-Graham</surname> <given-names>KF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Degradation of high affinity HuD targets releases Kv1.1 mRNA from miR-129 repression by mTORC1</article-title><source>The Journal of Cell Biology</source><volume>202</volume><fpage>53</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1083/jcb.201212089</pub-id><pub-id pub-id-type="pmid">23836929</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strickland</surname> <given-names>IT</given-names></name><name><surname>Richards</surname> <given-names>L</given-names></name><name><surname>Holmes</surname> <given-names>FE</given-names></name><name><surname>Wynick</surname> <given-names>D</given-names></name><name><surname>Uney</surname> <given-names>JB</given-names></name><name><surname>Wong</surname> <given-names>LF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Axotomy-induced miR-21 promotes axon growth in adult dorsal root ganglion neurons</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e23423</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0023423</pub-id><pub-id pub-id-type="pmid">21853131</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumner</surname> <given-names>CJ</given-names></name><name><surname>Kolb</surname> <given-names>SJ</given-names></name><name><surname>Harmison</surname> <given-names>GG</given-names></name><name><surname>Jeffries</surname> <given-names>NO</given-names></name><name><surname>Schadt</surname> <given-names>K</given-names></name><name><surname>Finkel</surname> <given-names>RS</given-names></name><name><surname>Dreyfuss</surname> <given-names>G</given-names></name><name><surname>Fischbeck</surname> <given-names>KH</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>SMN mRNA and protein levels in peripheral blood: biomarkers for SMA clinical trials</article-title><source>Neurology</source><volume>66</volume><fpage>1067</fpage><lpage>1073</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000201929.56928.13</pub-id><pub-id pub-id-type="pmid">16481599</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>S</given-names></name><name><surname>Ling</surname> <given-names>S-C</given-names></name><name><surname>Qiu</surname> <given-names>J</given-names></name><name><surname>Albuquerque</surname> <given-names>CP</given-names></name><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Tokunaga</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Qiu</surname> <given-names>H</given-names></name><name><surname>Bui</surname> <given-names>A</given-names></name><name><surname>Yeo</surname> <given-names>GW</given-names></name><name><surname>Huang</surname> <given-names>EJ</given-names></name><name><surname>Eggan</surname> <given-names>K</given-names></name><name><surname>Zhou</surname> <given-names>H</given-names></name><name><surname>Fu</surname> <given-names>X-D</given-names></name><name><surname>Lagier-Tourenne</surname> <given-names>C</given-names></name><name><surname>Cleveland</surname> <given-names>DW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>6171</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms7171</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>SÃ¼rmeli</surname> <given-names>G</given-names></name><name><surname>Akay</surname> <given-names>T</given-names></name><name><surname>Ippolito</surname> <given-names>GC</given-names></name><name><surname>Tucker</surname> <given-names>PW</given-names></name><name><surname>Jessell</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Patterns of spinal sensory-motor connectivity prescribed by a dorsoventral positional template</article-title><source>Cell</source><volume>147</volume><fpage>653</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.10.012</pub-id><pub-id pub-id-type="pmid">22036571</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tadesse</surname> <given-names>H</given-names></name><name><surname>DeschÃªnes-Furry</surname> <given-names>J</given-names></name><name><surname>Boisvenue</surname> <given-names>S</given-names></name><name><surname>CÃ´tÃ©</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>KH-type splicing regulatory protein interacts with survival motor neuron protein and is misregulated in spinal muscular atrophy</article-title><source>Human Molecular Genetics</source><volume>17</volume><fpage>506</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddm327</pub-id><pub-id pub-id-type="pmid">17998247</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taga</surname> <given-names>A</given-names></name><name><surname>Maragakis</surname> <given-names>NJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Current and emerging ALS biomarkers: utility and potential in clinical trials</article-title><source>Expert Review of Neurotherapeutics</source><volume>18</volume><fpage>871</fpage><lpage>886</lpage><pub-id pub-id-type="doi">10.1080/14737175.2018.1530987</pub-id><pub-id pub-id-type="pmid">30273061</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thaler</surname> <given-names>J</given-names></name><name><surname>Harrison</surname> <given-names>K</given-names></name><name><surname>Sharma</surname> <given-names>K</given-names></name><name><surname>Lettieri</surname> <given-names>K</given-names></name><name><surname>Kehrl</surname> <given-names>J</given-names></name><name><surname>Pfaff</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Active suppression of interneuron programs within developing motor neurons revealed by analysis of homeodomain factor HB9</article-title><source>Neuron</source><volume>23</volume><fpage>675</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(01)80027-1</pub-id><pub-id pub-id-type="pmid">10482235</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiebes</surname> <given-names>KP</given-names></name><name><surname>Nam</surname> <given-names>H</given-names></name><name><surname>Cambronne</surname> <given-names>XA</given-names></name><name><surname>Shen</surname> <given-names>R</given-names></name><name><surname>Glasgow</surname> <given-names>SM</given-names></name><name><surname>Cho</surname> <given-names>HH</given-names></name><name><surname>Kwon</surname> <given-names>JS</given-names></name><name><surname>Goodman</surname> <given-names>RH</given-names></name><name><surname>Lee</surname> <given-names>JW</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>miR-218 is essential to establish motor neuron fate as a downstream effector of Isl1-Lhx3</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>7718</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms8718</pub-id><pub-id pub-id-type="pmid">26212498</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toivonen</surname> <given-names>JM</given-names></name><name><surname>Manzano</surname> <given-names>R</given-names></name><name><surname>OlivÃ¡n</surname> <given-names>S</given-names></name><name><surname>Zaragoza</surname> <given-names>P</given-names></name><name><surname>GarcÃ­a-Redondo</surname> <given-names>A</given-names></name><name><surname>Osta</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e89065</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0089065</pub-id><pub-id pub-id-type="pmid">24586506</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trabucchi</surname> <given-names>M</given-names></name><name><surname>Briata</surname> <given-names>P</given-names></name><name><surname>Garcia-Mayoral</surname> <given-names>M</given-names></name><name><surname>Haase</surname> <given-names>AD</given-names></name><name><surname>Filipowicz</surname> <given-names>W</given-names></name><name><surname>Ramos</surname> <given-names>A</given-names></name><name><surname>Gherzi</surname> <given-names>R</given-names></name><name><surname>Rosenfeld</surname> <given-names>MG</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs</article-title><source>Nature</source><volume>459</volume><fpage>1010</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1038/nature08025</pub-id><pub-id pub-id-type="pmid">19458619</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchida</surname> <given-names>T</given-names></name><name><surname>Ensini</surname> <given-names>M</given-names></name><name><surname>Morton</surname> <given-names>SB</given-names></name><name><surname>Baldassare</surname> <given-names>M</given-names></name><name><surname>Edlund</surname> <given-names>T</given-names></name><name><surname>Jessell</surname> <given-names>TM</given-names></name><name><surname>Pfaff</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Topographic organization of embryonic motor neurons defined by expression of LIM homeobox genes</article-title><source>Cell</source><volume>79</volume><fpage>957</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(94)90027-2</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tu</surname> <given-names>WY</given-names></name><name><surname>Simpson</surname> <given-names>JE</given-names></name><name><surname>Highley</surname> <given-names>JR</given-names></name><name><surname>Heath</surname> <given-names>PR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Spinal muscular atrophy: factors that modulate motor neurone vulnerability</article-title><source>Neurobiology of Disease</source><volume>102</volume><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2017.01.011</pub-id><pub-id pub-id-type="pmid">28161391</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tung</surname> <given-names>YT</given-names></name><name><surname>Lu</surname> <given-names>YL</given-names></name><name><surname>Peng</surname> <given-names>KC</given-names></name><name><surname>Yen</surname> <given-names>YP</given-names></name><name><surname>Chang</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Jung</surname> <given-names>H</given-names></name><name><surname>Thams</surname> <given-names>S</given-names></name><name><surname>Huang</surname> <given-names>YP</given-names></name><name><surname>Hung</surname> <given-names>JH</given-names></name><name><surname>Chen</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mir-17â¼92 governs motor neuron subtype survival by mediating nuclear PTEN</article-title><source>Cell Reports</source><volume>11</volume><fpage>1305</fpage><lpage>1318</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.04.050</pub-id><pub-id pub-id-type="pmid">26004179</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tung</surname> <given-names>YT</given-names></name><name><surname>Peng</surname> <given-names>KC</given-names></name><name><surname>Chen</surname> <given-names>YC</given-names></name><name><surname>Yen</surname> <given-names>YP</given-names></name><name><surname>Chang</surname> <given-names>M</given-names></name><name><surname>Thams</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mir-17â¼92 confers motor neuron subtype differential resistance to ALS-Associated degeneration</article-title><source>Cell Stem Cell</source><volume>25</volume><fpage>193</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2019.04.016</pub-id><pub-id pub-id-type="pmid">31155482</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valsecchi</surname> <given-names>V</given-names></name><name><surname>Boido</surname> <given-names>M</given-names></name><name><surname>De Amicis</surname> <given-names>E</given-names></name><name><surname>Piras</surname> <given-names>A</given-names></name><name><surname>Vercelli</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Expression of Muscle-Specific MiRNA 206 in the progression of disease in a murine SMA model</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0128560</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0128560</pub-id><pub-id pub-id-type="pmid">26030275</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanderhorst</surname> <given-names>VG</given-names></name><name><surname>Holstege</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Organization of lumbosacral motoneuronal cell groups innervating hindlimb, pelvic floor, and axial muscles in the cat</article-title><source>The Journal of Comparative Neurology</source><volume>382</volume><fpage>46</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19970526)382:1&lt;46::AID-CNE4&gt;3.0.CO;2-K</pub-id><pub-id pub-id-type="pmid">9136811</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanderweyde</surname> <given-names>T</given-names></name><name><surname>Youmans</surname> <given-names>K</given-names></name><name><surname>Liu-Yesucevitz</surname> <given-names>L</given-names></name><name><surname>Wolozin</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Role of stress granules and RNA-binding proteins in neurodegeneration: a mini-review</article-title><source>Gerontology</source><volume>59</volume><fpage>524</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1159/000354170</pub-id><pub-id pub-id-type="pmid">24008580</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vermot</surname> <given-names>J</given-names></name><name><surname>Schuhbaur</surname> <given-names>B</given-names></name><name><surname>Le Mouellic</surname> <given-names>H</given-names></name><name><surname>McCaffery</surname> <given-names>P</given-names></name><name><surname>Garnier</surname> <given-names>JM</given-names></name><name><surname>Hentsch</surname> <given-names>D</given-names></name><name><surname>BrÃ»let</surname> <given-names>P</given-names></name><name><surname>Niederreither</surname> <given-names>K</given-names></name><name><surname>Chambon</surname> <given-names>P</given-names></name><name><surname>DollÃ©</surname> <given-names>P</given-names></name><name><surname>Le Roux</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Retinaldehyde dehydrogenase 2 and Hoxc8 are required in the murine brachial spinal cord for the specification of Lim1+ motoneurons and the correct distribution of Islet1+ motoneurons</article-title><source>Development</source><volume>132</volume><fpage>1611</fpage><lpage>1621</lpage><pub-id pub-id-type="doi">10.1242/dev.01718</pub-id><pub-id pub-id-type="pmid">15753214</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viswambharan</surname> <given-names>V</given-names></name><name><surname>Thanseem</surname> <given-names>I</given-names></name><name><surname>Vasu</surname> <given-names>MM</given-names></name><name><surname>Poovathinal</surname> <given-names>SA</given-names></name><name><surname>Anitha</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>miRNAs as biomarkers of neurodegenerative disorders</article-title><source>Biomarkers in Medicine</source><volume>11</volume><fpage>151</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.2217/bmm-2016-0242</pub-id><pub-id pub-id-type="pmid">28125293</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wadman</surname> <given-names>RI</given-names></name><name><surname>Stam</surname> <given-names>M</given-names></name><name><surname>Jansen</surname> <given-names>MD</given-names></name><name><surname>van der Weegen</surname> <given-names>Y</given-names></name><name><surname>Wijngaarde</surname> <given-names>CA</given-names></name><name><surname>Harschnitz</surname> <given-names>O</given-names></name><name><surname>Sodaar</surname> <given-names>P</given-names></name><name><surname>Braun</surname> <given-names>KP</given-names></name><name><surname>Dooijes</surname> <given-names>D</given-names></name><name><surname>Lemmink</surname> <given-names>HH</given-names></name><name><surname>van den Berg</surname> <given-names>LH</given-names></name><name><surname>van der Pol</surname> <given-names>WL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A comparative study of SMN protein and mRNA in blood and fibroblasts in patients with spinal muscular atrophy and healthy controls</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0167087</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0167087</pub-id><pub-id pub-id-type="pmid">27893852</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>IF</given-names></name><name><surname>Reddy</surname> <given-names>NM</given-names></name><name><surname>Shen</surname> <given-names>CK</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Higher order arrangement of the eukaryotic nuclear bodies</article-title><source>PNAS</source><volume>99</volume><fpage>13583</fpage><lpage>13588</lpage><pub-id pub-id-type="doi">10.1073/pnas.212483099</pub-id><pub-id pub-id-type="pmid">12361981</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wertz</surname> <given-names>MH</given-names></name><name><surname>Winden</surname> <given-names>K</given-names></name><name><surname>Neveu</surname> <given-names>P</given-names></name><name><surname>Ng</surname> <given-names>SY</given-names></name><name><surname>Ercan</surname> <given-names>E</given-names></name><name><surname>Sahin</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cell-type-specific miR-431 dysregulation in a motor neuron model of spinal muscular atrophy</article-title><source>Human Molecular Genetics</source><volume>25</volume><fpage>2168</fpage><lpage>2181</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddw084</pub-id><pub-id pub-id-type="pmid">27005422</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winkler</surname> <given-names>C</given-names></name><name><surname>Eggert</surname> <given-names>C</given-names></name><name><surname>Gradl</surname> <given-names>D</given-names></name><name><surname>Meister</surname> <given-names>G</given-names></name><name><surname>Giegerich</surname> <given-names>M</given-names></name><name><surname>Wedlich</surname> <given-names>D</given-names></name><name><surname>Laggerbauer</surname> <given-names>B</given-names></name><name><surname>Fischer</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Reduced U snRNP assembly causes motor axon degeneration in an animal model for spinal muscular atrophy</article-title><source>Genes &amp; Development</source><volume>19</volume><fpage>2320</fpage><lpage>2330</lpage><pub-id pub-id-type="doi">10.1101/gad.342005</pub-id><pub-id pub-id-type="pmid">16204184</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolter</surname> <given-names>JM</given-names></name><name><surname>Le</surname> <given-names>HH</given-names></name><name><surname>Linse</surname> <given-names>A</given-names></name><name><surname>Godlove</surname> <given-names>VA</given-names></name><name><surname>Nguyen</surname> <given-names>TD</given-names></name><name><surname>Kotagama</surname> <given-names>K</given-names></name><name><surname>Lynch</surname> <given-names>A</given-names></name><name><surname>Rawls</surname> <given-names>A</given-names></name><name><surname>Mangone</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Evolutionary patterns of metazoan microRNAs reveal targeting principles in the let-7 and miR-10 families</article-title><source>Genome Research</source><volume>27</volume><fpage>53</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1101/gr.209361.116</pub-id><pub-id pub-id-type="pmid">27927717</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>SF</given-names></name><name><surname>Agarwal</surname> <given-names>V</given-names></name><name><surname>Mansfield</surname> <given-names>JH</given-names></name><name><surname>Denans</surname> <given-names>N</given-names></name><name><surname>Schwartz</surname> <given-names>MG</given-names></name><name><surname>Prosser</surname> <given-names>HM</given-names></name><name><surname>PourquiÃ©</surname> <given-names>O</given-names></name><name><surname>Bartel</surname> <given-names>DP</given-names></name><name><surname>Tabin</surname> <given-names>CJ</given-names></name><name><surname>McGlinn</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Independent regulation of vertebral number and vertebral identity by microRNA-196 paralogs</article-title><source>PNAS</source><volume>112</volume><fpage>E4884</fpage><lpage>E4893</lpage><pub-id pub-id-type="doi">10.1073/pnas.1512655112</pub-id><pub-id pub-id-type="pmid">26283362</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Workman</surname> <given-names>E</given-names></name><name><surname>Saieva</surname> <given-names>L</given-names></name><name><surname>Carrel</surname> <given-names>TL</given-names></name><name><surname>Crawford</surname> <given-names>TO</given-names></name><name><surname>Liu</surname> <given-names>D</given-names></name><name><surname>Lutz</surname> <given-names>C</given-names></name><name><surname>Beattie</surname> <given-names>CE</given-names></name><name><surname>Pellizzoni</surname> <given-names>L</given-names></name><name><surname>Burghes</surname> <given-names>AH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice</article-title><source>Human Molecular Genetics</source><volume>18</volume><fpage>2215</fpage><lpage>2229</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddp157</pub-id><pub-id pub-id-type="pmid">19329542</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>S</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Capecchi</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Motoneurons and oligodendrocytes are sequentially generated from neural stem cells but do not appear to share common lineage-restricted progenitors in vivo</article-title><source>Development</source><volume>133</volume><fpage>581</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1242/dev.02236</pub-id><pub-id pub-id-type="pmid">16407399</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>D</given-names></name><name><surname>Murashov</surname> <given-names>AK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>MicroRNA-431 regulates axon regeneration in mature sensory neurons by targeting the wnt antagonist Kremen1</article-title><source>Frontiers in Molecular Neuroscience</source><volume>6</volume><elocation-id>35</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2013.00035</pub-id><pub-id pub-id-type="pmid">24167472</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>MicroRNAs in neurodegenerative disorders</article-title><source>Current Geriatrics Reports</source><volume>1</volume><fpage>214</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1007/s13670-012-0030-5</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamazaki</surname> <given-names>T</given-names></name><name><surname>Chen</surname> <given-names>S</given-names></name><name><surname>Yu</surname> <given-names>Y</given-names></name><name><surname>Yan</surname> <given-names>B</given-names></name><name><surname>Haertlein</surname> <given-names>TC</given-names></name><name><surname>Carrasco</surname> <given-names>MA</given-names></name><name><surname>Tapia</surname> <given-names>JC</given-names></name><name><surname>Zhai</surname> <given-names>B</given-names></name><name><surname>Das</surname> <given-names>R</given-names></name><name><surname>Lalancette-Hebert</surname> <given-names>M</given-names></name><name><surname>Sharma</surname> <given-names>A</given-names></name><name><surname>Chandran</surname> <given-names>S</given-names></name><name><surname>Sullivan</surname> <given-names>G</given-names></name><name><surname>Nishimura</surname> <given-names>AL</given-names></name><name><surname>Shaw</surname> <given-names>CE</given-names></name><name><surname>Gygi</surname> <given-names>SP</given-names></name><name><surname>Shneider</surname> <given-names>NA</given-names></name><name><surname>Maniatis</surname> <given-names>T</given-names></name><name><surname>Reed</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>FUS-SMN protein interactions link the motor neuron diseases ALS and SMA</article-title><source>Cell Reports</source><volume>2</volume><fpage>799</fpage><lpage>806</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2012.08.025</pub-id><pub-id pub-id-type="pmid">23022481</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yekta</surname> <given-names>S</given-names></name><name><surname>Tabin</surname> <given-names>CJ</given-names></name><name><surname>Bartel</surname> <given-names>DP</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>MicroRNAs in the hox network: an apparent link to posterior prevalence</article-title><source>Nature Reviews Genetics</source><volume>9</volume><fpage>789</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1038/nrg2400</pub-id><pub-id pub-id-type="pmid">18781158</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Q</given-names></name><name><surname>Anderson</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification</article-title><source>Cell</source><volume>109</volume><fpage>61</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(02)00677-3</pub-id><pub-id pub-id-type="pmid">11955447</pub-id></element-citation></ref></ref-list></back></article>